| SearchStrings |
| 1 | 7773 | 72.30 | &esrc=s |
| 2 | 142 | 1.32 | tropical journal of pharmaceutical resea... |
| 3 | 90 | 0.84 | tjpr |
| 4 | 45 | 0.42 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 5 | 40 | 0.37 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 6 | 33 | 0.31 | http://www.tjpr.org/vol8_no4/2009_8_4_3_... |
| 7 | 28 | 0.26 | pharmaceutical validation |
| 8 | 21 | 0.20 | 1 |
| 9 | 21 | 0.20 | nano drug delivery system pdf |
| 10 | 19 | 0.18 | http://www.tjpr.org/vol1%20no2/okhamafe1... |
| 11 | 19 | 0.18 | research articles on neosomes |
| 12 | 19 | 0.18 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 13 | 18 | 0.17 | journal distillation fractional |
| 14 | 18 | 0.17 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 15 | 17 | 0.16 | nanotechnology based drug delivery syste... |
| 16 | 15 | 0.14 | diabetes mellitus insulin hepatitis c ar... |
| 17 | 15 | 0.14 | (Google Cache) |
| 18 | 14 | 0.13 | drug delivery ionic liquid.pdf |
| 19 | 14 | 0.13 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 20 | 12 | 0.11 | chitosan-alginate microspheres+dsc analy... |
| 21 | 12 | 0.11 | http://www.tjpr.org/vol8_no2/2009_8_2_10... |
| 22 | 12 | 0.11 | mefenamic acid article filetype:pdf |
| 23 | 12 | 0.11 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 24 | 11 | 0.10 | biological properties of camphor , filet... |
| 25 | 11 | 0.10 | nano technology in drug delivery |
| 26 | 10 | 0.09 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 27 | 10 | 0.09 | trop j pharm res |
| 28 | 10 | 0.09 | tropical journal of pharmaceutical resea... |
| 29 | 10 | 0.09 | phytochemical screening of tinospora tub... |
| 30 | 9 | 0.08 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 31 | 9 | 0.08 | pharmacy care levels in hospital in nige... |
| 32 | 9 | 0.08 | filetype:pdf microbial contamination con... |
| 33 | 9 | 0.08 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 34 | 9 | 0.08 | tropical journal of pharmacetical res |
| 35 | 8 | 0.07 | variety of ways to prepare herbal toothp... |
| 36 | 8 | 0.07 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 37 | 8 | 0.07 | fast disintegrating tablets dissolution ... |
| 38 | 8 | 0.07 | http://www.tjpr.org/ |
| 39 | 8 | 0.07 | nano based drug delivery |
| 40 | 8 | 0.07 | acétylcholine sur duodénum in vitro |
| 41 | 8 | 0.07 | hiv protease docking unbound complex lig... |
| 42 | 8 | 0.07 | http://www.tjpr.org/vol7_no4/745_vijayan... |
| 43 | 8 | 0.07 | microspheres pdf |
| 44 | 8 | 0.07 | crosscarmellose sodium affect the dissil... |
| 45 | 7 | 0.07 | ionic liquid and drug.pdf |
| 46 | 7 | 0.07 | http://www.tjpr.org/vol7_no3/738_garg.pd... |
| 47 | 7 | 0.07 | effects of dioscorea bulbifera on alloxa... |
| 48 | 7 | 0.07 | validation in pharma |
| 49 | 7 | 0.07 | hawthorn fruit increases the antioxidant... |
| 50 | 7 | 0.07 | combination of synthetic anticancer drug... |
| 51 | 7 | 0.07 | effects of aluminum chloride on blood pr... |
| 52 | 7 | 0.07 | http://www.tjpr.org/vol7_no2/7210pachuau... |
| 53 | 7 | 0.07 | what is validation in pharma |
| 54 | 7 | 0.07 | ratio of coating solvent and coating mat... |
| 55 | 7 | 0.07 | effect of bitter kola on damage testes ... |
| 56 | 7 | 0.07 | formulation and evaluation of carvedilol... |
| 57 | 7 | 0.07 | pharmaceutical process validation |
| 58 | 6 | 0.06 | design of drug based ionic liquid.pdf |
| 59 | 6 | 0.06 | drug ingredients ionic liquid.pdf |
| 60 | 6 | 0.06 | tropical journal of |
| 61 | 6 | 0.06 | piper crocatum ruiz |
| 62 | 6 | 0.06 | benefit of using gliclazide in combinati... |
| 63 | 6 | 0.06 | &source=web |
| 64 | 6 | 0.06 | as internal control be-ta-actin immunobl... |
| 65 | 6 | 0.06 | multiparticulate drug delivery system |
| 66 | 6 | 0.06 | adriamycin hplc mobile phase |
| 67 | 6 | 0.06 | journal of tagetes erectus filetype:pdf ... |
| 68 | 6 | 0.06 | http://www.tjpr.org/vol8_no2/2009_8_2_11... |
| 69 | 5 | 0.05 | techniques for mfg for high half life ta... |
| 70 | 5 | 0.05 | what is process validation in pharma |
| 71 | 5 | 0.05 | tropical journal of pharmaceutical |
| 72 | 5 | 0.05 | doxorubicin hplc mobile phase |
| 73 | 5 | 0.05 | mass spectrometry bottled water brands |
| 74 | 5 | 0.05 | 2 |
| 75 | 5 | 0.05 | review articles on nanotechnology pdf |
| 76 | 5 | 0.05 | tropical of pharmaceutical research |
| 77 | 5 | 0.05 | http://tjpr.org/ |
| 78 | 5 | 0.05 | what are mechanism of mouth odour in rel... |
| 79 | 5 | 0.05 | rt-pcr for cox-2 |
| 80 | 5 | 0.05 | &si=beginffboth |
| 81 | 5 | 0.05 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 82 | 5 | 0.05 | microsphere of salbatumol |
| 83 | 5 | 0.05 | history nano drugs |
| 84 | 5 | 0.05 | beesoo sponge |
| 85 | 5 | 0.05 | article on validation process of solid d... |
| 86 | 5 | 0.05 | tropical journal |
| 87 | 5 | 0.05 | latest works done on leaf as antimicrobi... |
| 88 | 4 | 0.04 | http://www.tjpr.org/vol7_no2/725sahu.pdf |
| 89 | 4 | 0.04 | low c3 levels |
| 90 | 4 | 0.04 | http://www.tjpr.org/vol7_no1/713behera.p... |
| 91 | 4 | 0.04 | fast disintegrating tablets pdf |
| 92 | 4 | 0.04 | nano technology in drug delivery system ... |
| 93 | 4 | 0.04 | formulation and evaluation of glipizide ... |
| 94 | 4 | 0.04 | formulation and evaluation suppository |
| 95 | 4 | 0.04 | polynomial equation and water uptake of ... |
| 96 | 4 | 0.04 | hyginic and microbia quality of yoghurt ... |
| 97 | 4 | 0.04 | difference between aqueous and methanol ... |
| 98 | 4 | 0.04 | http://www.tjpr.org/vol8_no1/2009_8_1_12... |
| 99 | 4 | 0.04 | tropical j of pharma research |
| 100 | 4 | 0.04 | pharma validation?q=pharma validation |
| 101 | 4 | 0.04 | trop j pharm res |
| 102 | 4 | 0.04 | http://www.tjpr.org/vol10_no1/2011_10_1_... |
| 103 | 4 | 0.04 | mucoadhesive drug delivery system.pdf |
| 104 | 4 | 0.04 | &ptb=0d518527-b241-482c-b97c-da8c40dcc6c... |
| 105 | 4 | 0.04 | excipients used in modified-release tab... |
| 106 | 4 | 0.04 | nanotechnology and drug delivery |
| 107 | 4 | 0.04 | drug resistant bacteria in uti patients ... |
| 108 | 4 | 0.04 | research articles on sustained release |
| 109 | 4 | 0.04 | odt tablets |
| 110 | 4 | 0.04 | transdermal drug delivery system pdf?q=t... |
| 111 | 4 | 0.04 | zulfiker |
| 112 | 4 | 0.04 | ppt on multi unit particulate system |
| 113 | 4 | 0.04 | http://www.tjpr.org/vol8_no3/2009_8_3_11... |
| 114 | 4 | 0.04 | evaluation test of analgesic gels |
| 115 | 4 | 0.04 | lysine production in iran |
| 116 | 4 | 0.04 | http://www.tjpr.org/vol8_no4/2009_8_4_1_... |
| 117 | 4 | 0.04 | formulation of testmasking by solid disp... |
| 118 | 4 | 0.04 | tropical journal of pharmaceutical resea... |
| 119 | 4 | 0.04 | diffusion coefficient photoreceptor file... |
| 120 | 4 | 0.04 | tooth paste pdf |
| 121 | 4 | 0.04 | myrrh |
| 122 | 4 | 0.04 | herbal drugs used for oral disintegratin... |
| 123 | 4 | 0.04 | ftir electrostatic interaction |
| 124 | 4 | 0.04 | equipments used for process validation |
| 125 | 4 | 0.04 | the mechanism of mouth odour in relation... |
| 126 | 4 | 0.04 | &st=hp |
| 127 | 4 | 0.04 | review on gastroretentive drug delivery ... |
| 128 | 4 | 0.04 | oral delivery delayed release |
| 129 | 3 | 0.03 | validation of pharmaceutical formulation... |
| 130 | 3 | 0.03 | wavelength for quinones estimation |
| 131 | 3 | 0.03 | (silymarin measurement methods)pdf |
| 132 | 3 | 0.03 | http://www.tjpr.org/vol9_no4/2010_9_4_5.... |
| 133 | 3 | 0.03 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 134 | 3 | 0.03 | penitration medicine |
| 135 | 3 | 0.03 | dispensar can do practice medicine in pa... |
| 136 | 3 | 0.03 | discuss mechanism of mouth odour in rela... |
| 137 | 3 | 0.03 | chemical analysis of astonia boonei |
| 138 | 3 | 0.03 | extract cancer cell t47d apoptotic cycle... |
| 139 | 3 | 0.03 | tropical journal of pharmaceutical resea... |
| 140 | 3 | 0.03 | sustained release tablets review article... |
| 141 | 3 | 0.03 | prevalidation activities protocol prepar... |
| 142 | 3 | 0.03 | which system is affected by gloriosa sup... |
| 143 | 3 | 0.03 | chemistry drug enhancer |
| 144 | 3 | 0.03 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 145 | 3 | 0.03 | complement c3 c4 |
| 146 | 3 | 0.03 | validation of pharmaceutical equipment |
| 147 | 3 | 0.03 | eryngium caucasicum trautv filetype:pdf |
| 148 | 3 | 0.03 | ellman method cholinesterase activity me... |
| 149 | 3 | 0.03 | complication of brucellosis |
| 150 | 3 | 0.03 | ppts on anticonvulsant activity of plan... |
| 151 | 3 | 0.03 | antimicrobial activity of medicinal plan... |
| 152 | 3 | 0.03 | article on process validation of sterile... |
| 153 | 3 | 0.03 | herbal medicine pdf |
| 154 | 3 | 0.03 | milk article about reducing microbes+pdf |
| 155 | 3 | 0.03 | filetype:pdf drugs metabolism by microbe... |
| 156 | 3 | 0.03 | effects of medicinal plants on wound hea... |
| 157 | 3 | 0.03 | c3 and c4 levels |
| 158 | 3 | 0.03 | treatment on toxicity of langli (glorio... |
| 159 | 3 | 0.03 | tropical journal of pharmaceutical resea... |
| 160 | 3 | 0.03 | bilayer tablet |
| 161 | 3 | 0.03 | 5e30a66646c1f834aba48f9fed726b8c |
| 162 | 3 | 0.03 | qualification .pdf journal weigh drug |
| 163 | 3 | 0.03 | mic and discussion and s. aureus and bit... |
| 164 | 3 | 0.03 | penetration enhancer for hydrophilic dru... |
| 165 | 3 | 0.03 | medicinal plants, engineering of seconda... |
| 166 | 3 | 0.03 | http://www.tjpr.org/vol9_no4/2010_9_4_11... |
| 167 | 3 | 0.03 | f.h. tra bi; m.w. kone; n.f. kouame, tro... |
| 168 | 3 | 0.03 | pharmaceutical manufacturing validation |
| 169 | 3 | 0.03 | http://www.tjpr.org/vol8_no6/2009_8_6_1_... |
| 170 | 3 | 0.03 | gloriosa superba) |
| 171 | 3 | 0.03 | dimethyl isosorbide boiling point |
| 172 | 3 | 0.03 | microspheres prepartion pdf |
| 173 | 3 | 0.03 | the problem facing traditional medicine ... |
| 174 | 3 | 0.03 | journal of mefenamic acid |
| 175 | 3 | 0.03 | studies related to particular drugs in p... |
| 176 | 3 | 0.03 | case study related to gentamycin in pead... |
| 177 | 3 | 0.03 | silymarin extraction method |
| 178 | 3 | 0.03 | haais baatartsogt ouyngerel |
| 179 | 3 | 0.03 | equipment validation in pharmaceutical i... |
| 180 | 3 | 0.03 | &si=ciqlw-awxlocfwbmtaodwxyaca |
| 181 | 3 | 0.03 | new microspheres formulation of paracetm... |
| 182 | 3 | 0.03 | microorganism associated with pharmaceut... |
| 183 | 3 | 0.03 | does promethazine tablets dissolve |
| 184 | 3 | 0.03 | anti inflammatory activity of extracts f... |
| 185 | 3 | 0.03 | tropical journal of drug delivery |
| 186 | 3 | 0.03 | prepartion of microspheres pdf |
| 187 | 3 | 0.03 | michaelis constant photoreceptor filetyp... |
| 188 | 3 | 0.03 | application of nanotechnology in pharmac... |
| 189 | 3 | 0.03 | mahato, s. b., nandy, a. k., roy, g., 19... |
| 190 | 3 | 0.03 | eutragid rspo?q=eutragid rspo |
| 191 | 3 | 0.03 | oral tablet disintegrating?q= oral tabl... |
| 192 | 3 | 0.03 | suppositories pdf |
| 193 | 3 | 0.03 | toxicity of langli (gloriosa superba) |
| 194 | 3 | 0.03 | low c3 complement and normal c4 |
| 195 | 3 | 0.03 | ionic liquid+pharmacuitical+pdf |
| 196 | 3 | 0.03 | fast dissolving tablet using pore formin... |
| 197 | 3 | 0.03 | penetration enhancer |
| 198 | 3 | 0.03 | studies related to knowledge regarding g... |
| 199 | 3 | 0.03 | detection of blood alcohol by hplc |
| 200 | 3 | 0.03 | concentretion of ofloxacin in antimicrob... |
| 201 | 3 | 0.03 | nigerian medicinal plants with anticance... |
| 202 | 3 | 0.03 | validation in pharmacy |
| 203 | 3 | 0.03 | formulation of toothpaste |
| 204 | 3 | 0.03 | pdf microsperes?q=pdf microsperes |
| 205 | 3 | 0.03 | drug delivery review pdf |
| 206 | 3 | 0.03 | cedrus deodara activities pdf |
| 207 | 3 | 0.03 | c3 levels |
| 208 | 3 | 0.03 | pichiapastoris |
| 209 | 2 | 0.02 | synthesis of nanoparticles using calendu... |
| 210 | 2 | 0.02 | olic acid as penetration enhancer |
| 211 | 2 | 0.02 | download l pdf of anticholinesterases dr... |
| 212 | 2 | 0.02 | antioxidant and antimicrobial activity o... |
| 213 | 2 | 0.02 | tropical journal of |
| 214 | 2 | 0.02 | phytochemicals in pandiaka |
| 215 | 2 | 0.02 | effect on cardiovascular system extracts... |
| 216 | 2 | 0.02 | private intervention on rural and urban ... |
| 217 | 2 | 0.02 | intravenous lps-induced sepsis mice |
| 218 | 2 | 0.02 | http://www.tjpr.org/vol7_no1/717umachigi... |
| 219 | 2 | 0.02 | http://www.tjpr.org/vol8_no2/2009_8_2_3_... |
| 220 | 2 | 0.02 | biopharmaceutical characterisation of ci... |
| 221 | 2 | 0.02 | validation of equipment pharmaceutical |
| 222 | 2 | 0.02 | secamone afzelii rhoem |
| 223 | 2 | 0.02 | nephrotoxicity pdf |
| 224 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 225 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 226 | 2 | 0.02 | cohen m. systemic lupus erythematosus: d... |
| 227 | 2 | 0.02 | validation qa pharmaceutical |
| 228 | 2 | 0.02 | validation and types of validation in ph... |
| 229 | 2 | 0.02 | the usage pattern of non-steroidal anti-... |
| 230 | 2 | 0.02 | chemical enhancer |
| 231 | 2 | 0.02 | delphi standard for pharmaceutical care. |
| 232 | 2 | 0.02 | complement c3 and c4 deficiency |
| 233 | 2 | 0.02 | reaserch on formulation and preparation ... |
| 234 | 2 | 0.02 | modern pharmaceutical care in hospital |
| 235 | 2 | 0.02 | lupeol prostate cancer |
| 236 | 2 | 0.02 | jurnal formulasi obat tradisional antima... |
| 237 | 2 | 0.02 | c3 complement lupus |
| 238 | 2 | 0.02 | odt research articles pdf |
| 239 | 2 | 0.02 | scope of validation |
| 240 | 2 | 0.02 | all methods for preparation of micropart... |
| 241 | 2 | 0.02 | activate charcoal transit time in rat |
| 242 | 2 | 0.02 | molecular docking molecular dynamics |
| 243 | 2 | 0.02 | mechanism of penetration enhancers |
| 244 | 2 | 0.02 | solubility penetration relation |
| 245 | 2 | 0.02 | penetration enhanser |
| 246 | 2 | 0.02 | http://www.tjpr.org/vol7_no4/749_ofokans... |
| 247 | 2 | 0.02 | brucella and jaundice |
| 248 | 2 | 0.02 | mefenamic acid quality control test |
| 249 | 2 | 0.02 | http://www.tjpr.org/vol7_no4/748_ozcelik... |
| 250 | 2 | 0.02 | antibiogram of staphylococcus aureus in ... |
| 251 | 2 | 0.02 | stevia 2014 |
| 252 | 2 | 0.02 | t.s of boerhaavia |
| 253 | 2 | 0.02 | http://www.tjpr.org/vol7_no1/715erah.pdf |
| 254 | 2 | 0.02 | formulation and evaluation of sustained ... |
| 255 | 2 | 0.02 | desing,development and process validatio... |
| 256 | 2 | 0.02 | application of nanotechnology pdf file |
| 257 | 2 | 0.02 | suppository pdf |
| 258 | 2 | 0.02 | design validation of pharmaceuticals?q=d... |
| 259 | 2 | 0.02 | what is process validation in pharmaceut... |
| 260 | 2 | 0.02 | dental anti-caries mouthwash |
| 261 | 2 | 0.02 | decreased c3 and c4 serum complement |
| 262 | 2 | 0.02 | application of catalysis in drug deliver... |
| 263 | 2 | 0.02 | "muhammad imran amirzada" |
| 264 | 2 | 0.02 | stevia rebaudiana |
| 265 | 2 | 0.02 | scope and rationale of validation in pha... |
| 266 | 2 | 0.02 | pharmaceutical care for stroke patients |
| 267 | 2 | 0.02 | formulation and evaluation of sustained ... |
| 268 | 2 | 0.02 | brucella complication |
| 269 | 2 | 0.02 | nano technology in drugdelivery pdf |
| 270 | 2 | 0.02 | tjpr impact factor |
| 271 | 2 | 0.02 | sustained release metformin hydrochlorid... |
| 272 | 2 | 0.02 | microbial degradation of microbial produ... |
| 273 | 2 | 0.02 | phytoconstituent in anticholinesterase p... |
| 274 | 2 | 0.02 | dissolution profiles of tablet furosemid... |
| 275 | 2 | 0.02 | discuss mechanism of mouth odour and bac... |
| 276 | 2 | 0.02 | challenges of traditional medicine pdf |
| 277 | 2 | 0.02 | داروسازی در جنوب نیجر... |
| 278 | 2 | 0.02 | pharmaceutical validation and its types ... |
| 279 | 2 | 0.02 | &ptb=d1bec8ee-5fe4-4fa2-860c-94c51a6e4b3... |
| 280 | 2 | 0.02 | microspheres formulation |
| 281 | 2 | 0.02 | low complement c4 |
| 282 | 2 | 0.02 | ciproflxacin ir interpretation |
| 283 | 2 | 0.02 | "su zr" |
| 284 | 2 | 0.02 | salbutamol microkapsle formulation |
| 285 | 2 | 0.02 | resarch article in controlled relase ta... |
| 286 | 2 | 0.02 | personnel's involves in quality control |
| 287 | 2 | 0.02 | fractional crystallatio process of volat... |
| 288 | 2 | 0.02 | 4e654462017c4b4f547ef66a14141419 |
| 289 | 2 | 0.02 | synthesis of antiinflamantoy drugs |
| 290 | 2 | 0.02 | mechanosm of action of gloriosa superbap... |
| 291 | 2 | 0.02 | http://www.tjpr.org/jmanager/manuscript/... |
| 292 | 2 | 0.02 | oral controlled drug delivery system pdf |
| 293 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 294 | 2 | 0.02 | download w.h.o.technical report series 8... |
| 295 | 2 | 0.02 | content |
| 296 | 2 | 0.02 | bacteriological examination of milk by m... |
| 297 | 2 | 0.02 | water absorbance test in orally disinteg... |
| 298 | 2 | 0.02 | stevia |
| 299 | 2 | 0.02 | details of anticholinesterase pdf |
| 300 | 2 | 0.02 | validation of pharmaceutical equpments |
| 301 | 2 | 0.02 | change control procedure in pharma ppt |
| 302 | 2 | 0.02 | a048a4fe011aee50c2ec206a3092096c |
| 303 | 2 | 0.02 | phytoconstituent in anti cholinestarase ... |
| 304 | 2 | 0.02 | &si=cnfxm9327bgcfxqftaodxquajw |
| 305 | 2 | 0.02 | lifebioencapsulation |
| 306 | 2 | 0.02 | formulation and evaluation of matrix tab... |
| 307 | 2 | 0.02 | ccomplement c3 and c4 pdf |
| 308 | 2 | 0.02 | boswellia serrata gum extract research |
| 309 | 2 | 0.02 | articles on mefenamic acid pdf |
| 310 | 2 | 0.02 | ticagrelor hplc |
| 311 | 2 | 0.02 | pharna equipment vslidation n qualifica... |
| 312 | 2 | 0.02 | pharmacovigilance case reports |
| 313 | 2 | 0.02 | artemisinin combination therapy brand na... |
| 314 | 2 | 0.02 | validation in pharma manufacturing plant |
| 315 | 2 | 0.02 | penetration enhancer pdf |
| 316 | 2 | 0.02 | micbiogical evaluation of deffrent milk ... |
| 317 | 2 | 0.02 | 62e9753721aef4be6a36f3abff27bb0f |
| 318 | 2 | 0.02 | procedure for wetting time of tablet |
| 319 | 2 | 0.02 | flavonoids mechanism of action as laxati... |
| 320 | 2 | 0.02 | adverse effects of act |
| 321 | 2 | 0.02 | latest review article on transdermal pat... |
| 322 | 2 | 0.02 | tropical journal of pharm res |
| 323 | 2 | 0.02 | evaluation of sustained release formulat... |
| 324 | 2 | 0.02 | drugs from alstonia congensis |
| 325 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
| 326 | 2 | 0.02 | ethnobotany |
| 327 | 2 | 0.02 | solvent evaporation mwthod simvastatin m... |
| 328 | 2 | 0.02 | ppt of sustain release & controlled rele... |
| 329 | 2 | 0.02 | barkat.ali.955.faicbook |
| 330 | 2 | 0.02 | antitubercular activity |
| 331 | 2 | 0.02 | types of multiparticulate |
| 332 | 2 | 0.02 | increased c4 complement |
| 333 | 2 | 0.02 | [pdf] treatment brucellosis |
| 334 | 2 | 0.02 | review articles on retrospective validat... |
| 335 | 2 | 0.02 | chemical constituents of alstonia boonei... |
| 336 | 2 | 0.02 | mefenamic acid pdf |
| 337 | 2 | 0.02 | betahistine lc/ms determination |
| 338 | 2 | 0.02 | uv absorption maximum of losartan potass... |
| 339 | 2 | 0.02 | research article on microspheres |
| 340 | 2 | 0.02 | about cyproheptadine hydrochloride table... |
| 341 | 2 | 0.02 | pharma validation pdf |
| 342 | 2 | 0.02 | permeation enhancers used in transdermal... |
| 343 | 2 | 0.02 | k pavan kumar cm college of pharmacy sul... |
| 344 | 2 | 0.02 | brucella complications |
| 345 | 2 | 0.02 | tjpr.org |
| 346 | 2 | 0.02 | professor onyekweli anthony |
| 347 | 2 | 0.02 | infractive index of mixture of water and... |
| 348 | 2 | 0.02 | devlopment and evalution of chitosan fi... |
| 349 | 2 | 0.02 | conventional drug vs nano drug |
| 350 | 2 | 0.02 | ciprofloxacin topical drug review articl... |
| 351 | 2 | 0.02 | tropical jouranl of pharmacenutical rese... |
| 352 | 2 | 0.02 | raised serum c3 |
| 353 | 2 | 0.02 | myristica fragrans oil for vasodilator p... |
| 354 | 2 | 0.02 | multiparticulate drug delivery system pp... |
| 355 | 2 | 0.02 | gastroretentive drug delivery system |
| 356 | 2 | 0.02 | brucellosis complication |
| 357 | 2 | 0.02 | 5311f5096573b9193e74341acdcfad2f |
| 358 | 2 | 0.02 | description and uses of erygeron floribu... |
| 359 | 2 | 0.02 | control and assurance of manufaturing pr... |
| 360 | 2 | 0.02 | classification of controlled release dru... |
| 361 | 2 | 0.02 | sustain release tab evaluation |
| 362 | 2 | 0.02 | package insert perception |
| 363 | 2 | 0.02 | nano drug and biotechnology and review a... |
| 364 | 2 | 0.02 | control release system |
| 365 | 2 | 0.02 | pharmaceutical research 2 pdf |
| 366 | 2 | 0.02 | pdf review article targeting drug delive... |
| 367 | 2 | 0.02 | mouth desolving vomiting tablat |
| 368 | 2 | 0.02 | gastroretentive pdf |
| 369 | 2 | 0.02 | complement 3 |
| 370 | 2 | 0.02 | articlesof bilayer tablet |
| 371 | 2 | 0.02 | multiparticulate formulation pdf |
| 372 | 2 | 0.02 | formulation and evaluation of microspher... |
| 373 | 2 | 0.02 | sodium hydroxide quantity in raw cotton ... |
| 374 | 2 | 0.02 | il-12 radiation |
| 375 | 2 | 0.02 | test procedure of c3 c4 pdf |
| 376 | 2 | 0.02 | secamone afzelii rhoem?q=secamone afzeli... |
| 377 | 2 | 0.02 | pdf effect of different plant extract on... |
| 378 | 2 | 0.02 | orodispersible tablets |
| 379 | 2 | 0.02 | active drug layering |
| 380 | 2 | 0.02 | suitability indicating hplc method of dr... |
| 381 | 2 | 0.02 | promethazine drug pdf file |
| 382 | 2 | 0.02 | kang |
| 383 | 2 | 0.02 | tropical journal of pharmaceutical rese... |
| 384 | 2 | 0.02 | percutaneous drug absorption pdf |
| 385 | 2 | 0.02 | pdf bibliography of methanol |
| 386 | 2 | 0.02 | pharmaceutical validation pdf |
| 387 | 2 | 0.02 | pharmaceutical process validation pdf |
| 388 | 2 | 0.02 | “simultaneous determination” |
| 389 | 2 | 0.02 | stevia rebaudiana moisture content |
| 390 | 2 | 0.02 | orally disintegrating tablet |
| 391 | 2 | 0.02 | ellman method cholinesterase inhibitor i... |
| 392 | 2 | 0.02 | scope and objectives pharmaceutical tech... |
| 393 | 2 | 0.02 | pdf manufacturing process of selegiline ... |
| 394 | 2 | 0.02 | pdf of tbars |
| 395 | 2 | 0.02 | nutmeg for vasodilator effect pdf |
| 396 | 2 | 0.02 | extract diuretic |
| 397 | 2 | 0.02 | elevated c-4, normal c3 |
| 398 | 2 | 0.02 | brucellosis and alkaline phosphatase |
| 399 | 2 | 0.02 | penetration enhancer of transdermal patc... |
| 400 | 2 | 0.02 | formulation and preparation of microsphe... |
| 401 | 2 | 0.02 | control drug delivery dosage from |
| 402 | 2 | 0.02 | review article prodrug ppt |
| 403 | 2 | 0.02 | literature review of tablet and capsules |
| 404 | 2 | 0.02 | controlled release drug delivery system |
| 405 | 2 | 0.02 | benesi hildebrand plot |
| 406 | 2 | 0.02 | fast disintegration tablets |
| 407 | 2 | 0.02 | antimicrobial activity of some endemic p... |
| 408 | 2 | 0.02 | alcohol as penetration enhancer pdf |
| 409 | 2 | 0.02 | medicine transdermal agent |
| 410 | 2 | 0.02 | yeasts as milk spoilage organisms[pdf] |
| 411 | 2 | 0.02 | trop j phrm res,october 2013; 12(5):665 |
| 412 | 2 | 0.02 | ethanobotany pdf |
| 413 | 2 | 0.02 | define validation in pharma |
| 414 | 2 | 0.02 | stability indicating method development ... |
| 415 | 2 | 0.02 | processvalidation in pharmaceutical |
| 416 | 2 | 0.02 | preparation methods of microspheres. pdf |
| 417 | 2 | 0.02 | validation definition pharmaceutical |
| 418 | 2 | 0.02 | studies on good dispensing practices |
| 419 | 2 | 0.02 | penetration enhancers pdf |
| 420 | 2 | 0.02 | nanotechnology in medicine pdf file |
| 421 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 422 | 2 | 0.02 | oral dispersal tablet introduction |
| 423 | 2 | 0.02 | alstonia boonei?q=alstonia boonei |
| 424 | 2 | 0.02 | 5bf2c4eb374c5eccdc6679e732bc183f |
| 425 | 2 | 0.02 | what is multi particulate dosage form?q=... |
| 426 | 2 | 0.02 | sodium hypochlorite solution resistant ... |
| 427 | 2 | 0.02 | orally disintegration tablets by using c... |
| 428 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 429 | 2 | 0.02 | spermans correlation coefficient for det... |
| 430 | 2 | 0.02 | pdf files of virus management by nanotec... |
| 431 | 2 | 0.02 | http://www.tjpr.org/vol1%20no1/idowu.pdf |
| 432 | 2 | 0.02 | function assay test mefenamic acid |
| 433 | 2 | 0.02 | compactibility theophylline pdf |
| 434 | 2 | 0.02 | to prepare and evetuate microsphere |
| 435 | 2 | 0.02 | osmotic tablets pdf |
| 436 | 2 | 0.02 | title-abs-key(rapid and reliable hplc me... |
| 437 | 2 | 0.02 | skin penetration enhancers |
| 438 | 2 | 0.02 | knowledge attitute and practice towards ... |
| 439 | 2 | 0.02 | disintregation time of sublingual tablet... |
| 440 | 2 | 0.02 | tjpr rauwolfia |
| 441 | 2 | 0.02 | orodispersible tablet formulation and ev... |
| 442 | 2 | 0.02 | journal of titrimetric analysis of efedr... |
| 443 | 2 | 0.02 | block copolymers applications |
| 444 | 2 | 0.02 | commercialknowledge pdf |
| 445 | 2 | 0.02 | plants against multidrug resistance mic... |
| 446 | 2 | 0.02 | mouth dissolving dosage form and develop... |
| 447 | 2 | 0.02 | formulation and evaluation of acelofenac... |
| 448 | 1 | 0.01 | validation pharmaceutical |
| 449 | 1 | 0.01 | spheroidal oral drug absorption system (... |
| 450 | 1 | 0.01 | spectrophotometric assay of chloroquine ... |
| 451 | 1 | 0.01 | microspheres of different size in one do... |
| 452 | 1 | 0.01 | is oral b a nigeria product |
| 453 | 1 | 0.01 | normal c3 high c4 |
| 454 | 1 | 0.01 | penetration enhancers ppt |
| 455 | 1 | 0.01 | adjame pharmaceutical |
| 456 | 1 | 0.01 | antimicrobial activity of flavonoids |
| 457 | 1 | 0.01 | vicent okore pdf |
| 458 | 1 | 0.01 | complement c3 serum low |
| 459 | 1 | 0.01 | constituents in mimusops elengi |
| 460 | 1 | 0.01 | effects of literacy on commercial driver... |
| 461 | 1 | 0.01 | filetype:doc "response surface methodolo... |
| 462 | 1 | 0.01 | disintegrating agent to improve disinteg... |
| 463 | 1 | 0.01 | a novel derivatization ultraviolet spect... |
| 464 | 1 | 0.01 | benefits of lactobacillus pentosus |
| 465 | 1 | 0.01 | "phage display library" |
| 466 | 1 | 0.01 | a green and solvent-free process for pre... |
| 467 | 1 | 0.01 | solid dispersion formulation |
| 468 | 1 | 0.01 | polymers used in market for drug deliver... |
| 469 | 1 | 0.01 | toothpaste in open market |
| 470 | 1 | 0.01 | tamarindus indica filetype:pdf |
| 471 | 1 | 0.01 | validation of sterile manufacturing proc... |
| 472 | 1 | 0.01 | pharmacological action of antifertility ... |
| 473 | 1 | 0.01 | pdf antiulcer |
| 474 | 1 | 0.01 | penitration enhancers pdf |
| 475 | 1 | 0.01 | impact of vitamin b6 on gentamicin admin... |
| 476 | 1 | 0.01 | oral disintegrating tablets improved pa... |
| 477 | 1 | 0.01 | uv irradiation keratinocyte fibroblast c... |
| 478 | 1 | 0.01 | tramadol hydrochloride compatability |
| 479 | 1 | 0.01 | validation of manufacturing process in p... |
| 480 | 1 | 0.01 | validation process of pharmaceutical and... |
| 481 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
| 482 | 1 | 0.01 | the determination of arsenic content |
| 483 | 1 | 0.01 | trends of ethnobotany |
| 484 | 1 | 0.01 | nanotechnology in health care delivery i... |
| 485 | 1 | 0.01 | permeation enhancers for transdermal dru... |
| 486 | 1 | 0.01 | a reviw article on preparation and evalu... |
| 487 | 1 | 0.01 | review articles on orodispersible table... |
| 488 | 1 | 0.01 | sustained drug delivery system & its mar... |
| 489 | 1 | 0.01 | challenges of using traditional medicine... |
| 490 | 1 | 0.01 | available online at http://www.tjpr.org |
| 491 | 1 | 0.01 | brucellosis treatment in humans parenter... |
| 492 | 1 | 0.01 | effect of residual solvents on dissoluti... |
| 493 | 1 | 0.01 | g.a. ayoola article |
| 494 | 1 | 0.01 | nano biotechnology. in drug delivery |
| 495 | 1 | 0.01 | allergenic product tablet patent |
| 496 | 1 | 0.01 | eudragit rs mechanism |
| 497 | 1 | 0.01 | elicitor plants and nanoparticles |
| 498 | 1 | 0.01 | glipizide microspheres dissolution test |
| 499 | 1 | 0.01 | henry okeri |
| 500 | 1 | 0.01 | diuretic activity of medicinal plants |
| 501 | 1 | 0.01 | sodium citrate polymer pdf |
| 502 | 1 | 0.01 | signs and symptoms of recurrent brucella |
| 503 | 1 | 0.01 | systems used in drug delivery+pdf |
| 504 | 1 | 0.01 | khelmizadeh@qums.ac.ir loc:us |
| 505 | 1 | 0.01 | lupus low coplement c3 c$ |
| 506 | 1 | 0.01 | packaging of tablet dosage formreview a... |
| 507 | 1 | 0.01 | pharmaceutical mucoadhesion drug deliver... |
| 508 | 1 | 0.01 | stevia microbial |
| 509 | 1 | 0.01 | hpmc k100m and ec for sustained release... |
| 510 | 1 | 0.01 | odt tablets and insoluble api |
| 511 | 1 | 0.01 | 10. reddy kr., mutalik s, reddy s. “fo... |
| 512 | 1 | 0.01 | "phase 3" process development performanc... |
| 513 | 1 | 0.01 | tjpr, muselin |
| 514 | 1 | 0.01 | filetype:pdf validity and the process of... |
| 515 | 1 | 0.01 | activity of carissa carandas |
| 516 | 1 | 0.01 | gentamicin+ nephrotoxicity+ rat |
| 517 | 1 | 0.01 | hari nath dwivedi pharmacy bbd |
| 518 | 1 | 0.01 | what is abiotic cooling |
| 519 | 1 | 0.01 | oral disintegrating tablet formulation |
| 520 | 1 | 0.01 | l-asparaginase cost |
| 521 | 1 | 0.01 | enzyme production from actinomycetes |
| 522 | 1 | 0.01 | celecoxib and dmso as penetration enhanc... |
| 523 | 1 | 0.01 | how fare compliment c3 c4 on there diagn... |
| 524 | 1 | 0.01 | health care seeking behaviour among care... |
| 525 | 1 | 0.01 | ir spectra of carbopol 934 |
| 526 | 1 | 0.01 | mechanism of action of abortifacient pla... |
| 527 | 1 | 0.01 | http://www.tjpr.org/vol8_no4/2009_8_4_10... |
| 528 | 1 | 0.01 | czech journal of pharmaceutical research |
| 529 | 1 | 0.01 | complement level in blood |
| 530 | 1 | 0.01 | serum complement levels |
| 531 | 1 | 0.01 | solvent evaporation method pdf |
| 532 | 1 | 0.01 | spwcification of fast disnitegrating tab... |
| 533 | 1 | 0.01 | complete detail about ipqa in pharma ind... |
| 534 | 1 | 0.01 | comparative clinical study on the effect... |
| 535 | 1 | 0.01 | "healthy male volunteers" |
| 536 | 1 | 0.01 | permeation enhancer in transdermal patch |
| 537 | 1 | 0.01 | positive ana low c3 positive rnp c4 norm... |
| 538 | 1 | 0.01 | cefuroxime axetil physiochemical propert... |
| 539 | 1 | 0.01 | antimicrobial efficacy of garcinia kola |
| 540 | 1 | 0.01 | efficacy of toothpaste on the microbial ... |
| 541 | 1 | 0.01 | cotten candy process of product formulat... |
| 542 | 1 | 0.01 | assay of chloroquine sulphate using cali... |
| 543 | 1 | 0.01 | antibacterial properties of rhizopus?p=a... |
| 544 | 1 | 0.01 | lecithin ir spectra |
| 545 | 1 | 0.01 | international organisations for research... |
| 546 | 1 | 0.01 | nanodrug delivery essay |
| 547 | 1 | 0.01 | mouth dissolving tablet for emesis |
| 548 | 1 | 0.01 | parasite development stages + problems +... |
| 549 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 550 | 1 | 0.01 | chitosan thiolated |
| 551 | 1 | 0.01 | reported case of paracetamol and non-ste... |
| 552 | 1 | 0.01 | registration of pharmacy in bangladesh |
| 553 | 1 | 0.01 | formulation and evaluation of sustained ... |
| 554 | 1 | 0.01 | dsc of furosemide |
| 555 | 1 | 0.01 | is complement c4 blood test an indicator... |
| 556 | 1 | 0.01 | ipqa in tablet filetype:pdf |
| 557 | 1 | 0.01 | okori alamanda |
| 558 | 1 | 0.01 | laxative pdf |
| 559 | 1 | 0.01 | how is oral disintegrating tabs absorb |
| 560 | 1 | 0.01 | how much mcc used in floating tablet |
| 561 | 1 | 0.01 | drug delivery and biological motor |
| 562 | 1 | 0.01 | discussion of chloroquine phosphate tabl... |
| 563 | 1 | 0.01 | formulation and evaluation of meloxicam ... |
| 564 | 1 | 0.01 | polimer in immediate drug release dosage... |
| 565 | 1 | 0.01 | oximes in organophosphorus poisoning |
| 566 | 1 | 0.01 | piperine plasma hplc |
| 567 | 1 | 0.01 | rat skin erythema photoprotective |
| 568 | 1 | 0.01 | research articles in enzyme production f... |
| 569 | 1 | 0.01 | differential scanning calorimetric oil |
| 570 | 1 | 0.01 | c3 and c4 levels in sle |
| 571 | 1 | 0.01 | brucellosis treatment in humans pdf |
| 572 | 1 | 0.01 | complement c3 and dsdna in sle |
| 573 | 1 | 0.01 | pregnancy oriented name for products |
| 574 | 1 | 0.01 | intitle:nanotechnology "drug delivery" |
| 575 | 1 | 0.01 | low c3 low c4 |
| 576 | 1 | 0.01 | preparation and characterization of micr... |
| 577 | 1 | 0.01 | antibacterial activity of newbouldia lae... |
| 578 | 1 | 0.01 | complications of brucellosis |
| 579 | 1 | 0.01 | bed temperature for eudagit polymers |
| 580 | 1 | 0.01 | articles on anticancer activity of methi... |
| 581 | 1 | 0.01 | carissa carandas activity pdf in 2000 |
| 582 | 1 | 0.01 | design and development of halogenated ch... |
| 583 | 1 | 0.01 | definition of validation in pharmacutica... |
| 584 | 1 | 0.01 | history of nano drug delivery systems |
| 585 | 1 | 0.01 | formulation procefure for microsphere by... |
| 586 | 1 | 0.01 | define validation in pharmaceutical comp... |
| 587 | 1 | 0.01 | complication of brucellosis in india |
| 588 | 1 | 0.01 | what are the problems the orthodox medic... |
| 589 | 1 | 0.01 | pulsatile drug delivery system formulati... |
| 590 | 1 | 0.01 | pharmaceutical processes pdf |
| 591 | 1 | 0.01 | tropical journa |
| 592 | 1 | 0.01 | panadol purchase intention |
| 593 | 1 | 0.01 | multiple unit particulate systems |
| 594 | 1 | 0.01 | odt technology tablets |
| 595 | 1 | 0.01 | filetype:pdf antioxidant activity in ast... |
| 596 | 1 | 0.01 | diabetes and chemical enhancers |
| 597 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 598 | 1 | 0.01 | pharmacy practice nigeria |
| 599 | 1 | 0.01 | pyrazoline derivatives as analgesic agen... |
| 600 | 1 | 0.01 | c-4 complement level |
| 601 | 1 | 0.01 | benefits of odt in psychiatric patients |
| 602 | 1 | 0.01 | aleem-ma 111@yahoo.co.in |
| 603 | 1 | 0.01 | usp sennosides tablets |
| 604 | 1 | 0.01 | article on convection diffusion math in ... |
| 605 | 1 | 0.01 | summary of aqueous nasal dosage forms |
| 606 | 1 | 0.01 | trolamine salicylate |
| 607 | 1 | 0.01 | transdermal drug delivery system |
| 608 | 1 | 0.01 | tropical pharmaceutical |
| 609 | 1 | 0.01 | diabetes compliance research article |
| 610 | 1 | 0.01 | chemical composition piper crocatum ruiz... |
| 611 | 1 | 0.01 | c3 in sle |
| 612 | 1 | 0.01 | cefuroxime bcs class |
| 613 | 1 | 0.01 | erigeron floribundus |
| 614 | 1 | 0.01 | steps involve in pharmaceutical engineer... |
| 615 | 1 | 0.01 | penetration enhancement by sulphoxides |
| 616 | 1 | 0.01 | preparation of tramadol sr tablets using... |
| 617 | 1 | 0.01 | novel methods of drug delivery to skin r... |
| 618 | 1 | 0.01 | oleoyl macrogol 6 glycerides |
| 619 | 1 | 0.01 | has the formulation of senokot tablets c... |
| 620 | 1 | 0.01 | chemical responsible for diuretic activi... |
| 621 | 1 | 0.01 | drug delivery in nanotechnology |
| 622 | 1 | 0.01 | introduction to reserpine pdf |
| 623 | 1 | 0.01 | hpmcp and talc coating |
| 624 | 1 | 0.01 | journal of pharmacy on eschelia coli |
| 625 | 1 | 0.01 | alcohol induced peptic ulcer.pdf |
| 626 | 1 | 0.01 | bacterial load on medicine packages |
| 627 | 1 | 0.01 | torpical journal of pharmaceutical resea... |
| 628 | 1 | 0.01 | validation pharma |
| 629 | 1 | 0.01 | chitosan particle size and zeta potentia... |
| 630 | 1 | 0.01 | c3 c4 sle |
| 631 | 1 | 0.01 | caffeine and penicillin |
| 632 | 1 | 0.01 | permeation enhancers |
| 633 | 1 | 0.01 | filetype:pdf aspects of research and dev... |
| 634 | 1 | 0.01 | disintegration times of metronidazole |
| 635 | 1 | 0.01 | analysis of chloroquine phosphate using ... |
| 636 | 1 | 0.01 | c4 serum |
| 637 | 1 | 0.01 | interaction of sodium alginate and chito... |
| 638 | 1 | 0.01 | how penetration enhancers are used |
| 639 | 1 | 0.01 | formulation and evaluation microsphere |
| 640 | 1 | 0.01 | formulation extract tablet |
| 641 | 1 | 0.01 | osmotic pump drug delivery system in pdf |
| 642 | 1 | 0.01 | multiplex cyp2d6 |
| 643 | 1 | 0.01 | nanotechnology in drugs |
| 644 | 1 | 0.01 | ruijin yang, jiangnan |
| 645 | 1 | 0.01 | rphplc method for estimation of nevirap... |
| 646 | 1 | 0.01 | salvia antifungal |
| 647 | 1 | 0.01 | tropical journal of pharm |
| 648 | 1 | 0.01 | tartaric acid powder used formulation an... |
| 649 | 1 | 0.01 | photoaging, spf enhancer |
| 650 | 1 | 0.01 | journal of chemistry of drugs having ant... |
| 651 | 1 | 0.01 | pradere, bacteria, antitumor, 2013 |
| 652 | 1 | 0.01 | drug delivery with c60 + review + pdf |
| 653 | 1 | 0.01 | effect of extracton cd4 |
| 654 | 1 | 0.01 | characterization of bacteria found in mi... |
| 655 | 1 | 0.01 | brine shrimp assay |
| 656 | 1 | 0.01 | what could be done to improve pharmaceut... |
| 657 | 1 | 0.01 | &si=newtv |
| 658 | 1 | 0.01 | concepts of validation pdf |
| 659 | 1 | 0.01 | chitasan particle mol weight |
| 660 | 1 | 0.01 | cleaning process variables procedures ph... |
| 661 | 1 | 0.01 | evaluation of mouth wash |
| 662 | 1 | 0.01 | review article on mouth dissolving table... |
| 663 | 1 | 0.01 | nanotechnology pdf |
| 664 | 1 | 0.01 | detection of e coli producing asparagina... |
| 665 | 1 | 0.01 | gastroretentive drug delivery system pdf |
| 666 | 1 | 0.01 | international journal of pharma |
| 667 | 1 | 0.01 | hypromellose coating solution solvent |
| 668 | 1 | 0.01 | modern ethnobotany |
| 669 | 1 | 0.01 | formulation and development of pulsatile... |
| 670 | 1 | 0.01 | plants showing anticonvulsant activity ... |
| 671 | 1 | 0.01 | mouth dissolving tablet theory |
| 672 | 1 | 0.01 | original search articles on local drug d... |
| 673 | 1 | 0.01 | validation |
| 674 | 1 | 0.01 | searchbox |
| 675 | 1 | 0.01 | kinetica 4.6 kg |
| 676 | 1 | 0.01 | lps induced inos |
| 677 | 1 | 0.01 | deodar oil is antiinflammatory |
| 678 | 1 | 0.01 | designing of modulated release drug deli... |
| 679 | 1 | 0.01 | trolamine salicylate properties |
| 680 | 1 | 0.01 | thesis of aceclofenac sustained release ... |
| 681 | 1 | 0.01 | transdermal spray contraception journal |
| 682 | 1 | 0.01 | c3 test and lupus |
| 683 | 1 | 0.01 | validation of pharmaceutical processes |
| 684 | 1 | 0.01 | cache:http://www.tjpr.org/vol10_no3/2011... |
| 685 | 1 | 0.01 | traditional medicine in nigeria(pdf) |
| 686 | 1 | 0.01 | organic nanostructured nanoparticles + d... |
| 687 | 1 | 0.01 | pathcauly oil component and boiling poin... |
| 688 | 1 | 0.01 | observation of role of green chemistry i... |
| 689 | 1 | 0.01 | odt formaulation |
| 690 | 1 | 0.01 | tropical journal of pharma research |
| 691 | 1 | 0.01 | c3low c4 normal range |
| 692 | 1 | 0.01 | http://www.tjpr.org/vol11_no1/2012_11_1_... |
| 693 | 1 | 0.01 | flavonoids based pharmaceuticals |
| 694 | 1 | 0.01 | drug distribution in the vitreous humor ... |
| 695 | 1 | 0.01 | herbal toothpaste formulation |
| 696 | 1 | 0.01 | akkol@akkol.com.tr loc:us |
| 697 | 1 | 0.01 | 99350103 |
| 698 | 1 | 0.01 | actm maralia treatment side effects |
| 699 | 1 | 0.01 | c3 c4 measurement |
| 700 | 1 | 0.01 | anticancer and chalcones |
| 701 | 1 | 0.01 | cristina teodor romeo*usamvb faculty of ... |
| 702 | 1 | 0.01 | pdf on mechanism of release of different... |
| 703 | 1 | 0.01 | mohammed abdalbasit a gasmalla researche... |
| 704 | 1 | 0.01 | pdf on introduction classfication and ad... |
| 705 | 1 | 0.01 | hygroscopic orally disintegrating tablet... |
| 706 | 1 | 0.01 | sheeba rani |
| 707 | 1 | 0.01 | validation process in pharmaceutical |
| 708 | 1 | 0.01 | urolithiatic activity in plant |
| 709 | 1 | 0.01 | alginate calcium film+iran |
| 710 | 1 | 0.01 | preparation of microspheres research art... |
| 711 | 1 | 0.01 | process clining validation and its valid... |
| 712 | 1 | 0.01 | nanotechnology and drug delivery part 1 |
| 713 | 1 | 0.01 | l-asparaginase solid state fermentation |
| 714 | 1 | 0.01 | evaluation of rapidly disintegrating ... |
| 715 | 1 | 0.01 | antiasthmatic drug formulation |
| 716 | 1 | 0.01 | direct-compression excipient for orally ... |
| 717 | 1 | 0.01 | hplc stability indicating method |
| 718 | 1 | 0.01 | evaluation of sustained release formulat... |
| 719 | 1 | 0.01 | is salicylic acid hydrophobic to lipids ... |
| 720 | 1 | 0.01 | cefadroxil lambda max |
| 721 | 1 | 0.01 | c3 higher than normal |
| 722 | 1 | 0.01 | approaches and technologies for developi... |
| 723 | 1 | 0.01 | evaluation of solid dispersion by differ... |
| 724 | 1 | 0.01 | clinical advantage of drugs bypassing 1s... |
| 725 | 1 | 0.01 | discussion on sesamum indicum linn |
| 726 | 1 | 0.01 | antibacterial effect of garden cress (pd... |
| 727 | 1 | 0.01 | validation process in pharmaceutical ind... |
| 728 | 1 | 0.01 | use of chloroform in extraction of chlor... |
| 729 | 1 | 0.01 | tnfa pge2 |
| 730 | 1 | 0.01 | nano drug delivery system |
| 731 | 1 | 0.01 | knowledge of drug right in malaysia |
| 732 | 1 | 0.01 | low serum complement level indicate? |
| 733 | 1 | 0.01 | paclitaxel derivatives |
| 734 | 1 | 0.01 | spectrophotometric methods on oxycodone |
| 735 | 1 | 0.01 | cotten candy process of odt product form... |
| 736 | 1 | 0.01 | a2d816105be1c5d140f41dae282b922c |
| 737 | 1 | 0.01 | bilayer tablet pdf |
| 738 | 1 | 0.01 | tropical journal of pharmaceutical |
| 739 | 1 | 0.01 | sustained release microsphere+water solu... |
| 740 | 1 | 0.01 | plant extract+anticancer |
| 741 | 1 | 0.01 | croscarmellose sodium research articles |
| 742 | 1 | 0.01 | in process control of pharmaceuticals |
| 743 | 1 | 0.01 | journal of pharmaceutical |
| 744 | 1 | 0.01 | myristica fragrans and cholesterol.pdf |
| 745 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 746 | 1 | 0.01 | hpmc sustained release stability |
| 747 | 1 | 0.01 | complement c4, serum high |
| 748 | 1 | 0.01 | chalcones as anticancer agents |
| 749 | 1 | 0.01 | discriminatory dissolution media for lum... |
| 750 | 1 | 0.01 | compression of multiparticulate system |
| 751 | 1 | 0.01 | effect of dpph under nanoparticles |
| 752 | 1 | 0.01 | some physical characteristics of microcr... |
| 753 | 1 | 0.01 | serum complement |
| 754 | 1 | 0.01 | sle and c4 level |
| 755 | 1 | 0.01 | normal c3 levels |
| 756 | 1 | 0.01 | validation in pharmaceutical |
| 757 | 1 | 0.01 | transdermal drug delivery penetration en... |
| 758 | 1 | 0.01 | acetophenone dynamics docking filetype:... |
| 759 | 1 | 0.01 | alkyd resin pdf |
| 760 | 1 | 0.01 | scholarly articles about how to reduce w... |
| 761 | 1 | 0.01 | normal oral flora+toothpastes |
| 762 | 1 | 0.01 | microbial contamination in creams |
| 763 | 1 | 0.01 | pyrazoline |
| 764 | 1 | 0.01 | general orally disintegrating tablets pr... |
| 765 | 1 | 0.01 | dog beagle laboratory |
| 766 | 1 | 0.01 | low complement c3 plasma concentration |
| 767 | 1 | 0.01 | research articles on sr tablet system |
| 768 | 1 | 0.01 | references of antimicrobial activity of ... |
| 769 | 1 | 0.01 | gastro retentive controlled systems |
| 770 | 1 | 0.01 | nanotechnology in drugs pdf |
| 771 | 1 | 0.01 | salim a. hamadi |
| 772 | 1 | 0.01 | serum c3 c4 |
| 773 | 1 | 0.01 | wavelength of chloroquine |
| 774 | 1 | 0.01 | can nano crystal tablets be crushed? |
| 775 | 1 | 0.01 | method and materials quercus infectoria ... |
| 776 | 1 | 0.01 | insulin chitosan nanoparticles |
| 777 | 1 | 0.01 | knowledge of rural dwellers on key house... |
| 778 | 1 | 0.01 | fast dissolving tablets pdf |
| 779 | 1 | 0.01 | formulation and evaluation of sustained ... |
| 780 | 1 | 0.01 | aceclofenac |
| 781 | 1 | 0.01 | use of urea as penetration agent |
| 782 | 1 | 0.01 | &ptb=2342065e-4a84-4df6-9299-cf106240a6f... |
| 783 | 1 | 0.01 | controlled or release or pesticides nano... |
| 784 | 1 | 0.01 | activité inhibitrice alpha amylase file... |
| 785 | 1 | 0.01 | dmso technique for methanol extract |
| 786 | 1 | 0.01 | اعتبار سنجی دارویی |
| 787 | 1 | 0.01 | theory for spectrophtometry estimation ... |
| 788 | 1 | 0.01 | sardar yar khan hamdard university dly |
| 789 | 1 | 0.01 | toothpaste formulation pdf |
| 790 | 1 | 0.01 | breath alcohol analyser in portharcourt ... |
| 791 | 1 | 0.01 | analgesic herbal drugs with mechanism |
| 792 | 1 | 0.01 | article about drug delevery+nano+pdf |
| 793 | 1 | 0.01 | efect of boiling on saponins |
| 794 | 1 | 0.01 | review article on fast dissolving tablet... |
| 795 | 1 | 0.01 | normal human specific crp values in rat |
| 796 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 797 | 1 | 0.01 | multiparticulate systems |
| 798 | 1 | 0.01 | ways of eradication of malaria among com... |
| 799 | 1 | 0.01 | tropical journal pharmaceutical science |
| 800 | 1 | 0.01 | dysent?rie dans le monde |
| 801 | 1 | 0.01 | complement levels in sle |
| 802 | 1 | 0.01 | equipment validation in pharma |
| 803 | 1 | 0.01 | coconut shell has antimicrobial activity |
| 804 | 1 | 0.01 | analysis of chloroquine phosphate using ... |
| 805 | 1 | 0.01 | valleri m., et al., development and eval... |
| 806 | 1 | 0.01 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 807 | 1 | 0.01 | http://www.tjpr.org/vol12_no6/2013_12_6_... |
| 808 | 1 | 0.01 | intestinal smooth muscle contraction in ... |
| 809 | 1 | 0.01 | nanoparticle elicitor plant cell seconda... |
| 810 | 1 | 0.01 | analytical method development of meloxic... |
| 811 | 1 | 0.01 | escherichia coli urinary tract infectio... |
| 812 | 1 | 0.01 | uti pakistan antibiotics |
| 813 | 1 | 0.01 | self medication prevention |
| 814 | 1 | 0.01 | t.p hadjiioannou, g.d. christian, m.a. k... |
| 815 | 1 | 0.01 | ritu barthwal email |
| 816 | 1 | 0.01 | spectrophotometric methods for losartan |
| 817 | 1 | 0.01 | thiolated chitosans: novel polymers for ... |
| 818 | 1 | 0.01 | tlc solvent systems for starch.pdf |
| 819 | 1 | 0.01 | kap students |
| 820 | 1 | 0.01 | drug validation |
| 821 | 1 | 0.01 | design development and process validatio... |
| 822 | 1 | 0.01 | how to calculate entrapment efficiency o... |
| 823 | 1 | 0.01 | process validation review pdf |
| 824 | 1 | 0.01 | preparation of microspheres by the solve... |
| 825 | 1 | 0.01 | procedure for evaluation of hepatoprotec... |
| 826 | 1 | 0.01 | promethazine dissolution medium] |
| 827 | 1 | 0.01 | recent chemicals used in drug delivery |
| 828 | 1 | 0.01 | pdf of multparticulate drug delivery sys... |
| 829 | 1 | 0.01 | nephrotoxicity pdf in 2013 |
| 830 | 1 | 0.01 | mohammed a.a. gasmalla |
| 831 | 1 | 0.01 | lupus low complement c3, high complement... |
| 832 | 1 | 0.01 | multiparticulate dosage form |
| 833 | 1 | 0.01 | formulation and evaluation of sustained ... |
| 834 | 1 | 0.01 | drug release mechanism patch transdermal... |
| 835 | 1 | 0.01 | estimation of 5 drugs using uv spectros... |
| 836 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/731_editora... |
| 837 | 1 | 0.01 | list the group of drug in artemisinin co... |
| 838 | 1 | 0.01 | low c3 level |
| 839 | 1 | 0.01 | stages of validation |
| 840 | 1 | 0.01 | taha naji jiangnan |
| 841 | 1 | 0.01 | measurement of silymarin and the other c... |
| 842 | 1 | 0.01 | latest pharma validation guidelines |
| 843 | 1 | 0.01 | mechanism of drug skin absorption enhanc... |
| 844 | 1 | 0.01 | antifertility drugs invivo and invitro p... |
| 845 | 1 | 0.01 | aim of pharmaceutical validation |
| 846 | 1 | 0.01 | analysis of chloroquine phosphate using ... |
| 847 | 1 | 0.01 | bioadhesive polymeric platforms for tran... |
| 848 | 1 | 0.01 | urolithiasis, herbal |
| 849 | 1 | 0.01 | penetration enhancer of transdermal drug... |
| 850 | 1 | 0.01 | pharmaceutical validation. |
| 851 | 1 | 0.01 | multiparticulate floating system various... |
| 852 | 1 | 0.01 | manufacturing of aqueous nasal dosage fo... |
| 853 | 1 | 0.01 | niosomepharmacel application filetype:pd... |
| 854 | 1 | 0.01 | formulation development of mouth dissolv... |
| 855 | 1 | 0.01 | drug delivery nanotechnology |
| 856 | 1 | 0.01 | effect of artemisinin combined therapy o... |
| 857 | 1 | 0.01 | journal of pharmaceutical sciences & res... |
| 858 | 1 | 0.01 | low c4 complement and lupus |
| 859 | 1 | 0.01 | bioadhesive vaginal tablet pdf from inte... |
| 860 | 1 | 0.01 | analysisi borhole water, ademoroti |
| 861 | 1 | 0.01 | haiyprh transferrin tfr competitiveness |
| 862 | 1 | 0.01 | development of losartan formulation pdf |
| 863 | 1 | 0.01 | evaluation and formulation of sustained ... |
| 864 | 1 | 0.01 | in process control validation fda |
| 865 | 1 | 0.01 | is it more effective to inject peptides ... |
| 866 | 1 | 0.01 | validation process in pharma |
| 867 | 1 | 0.01 | pdf files on emulsion |
| 868 | 1 | 0.01 | physicochemical charaterization and diss... |
| 869 | 1 | 0.01 | factors that contribute to errors in ped... |
| 870 | 1 | 0.01 | medicinal plants and herbs pdf |
| 871 | 1 | 0.01 | medicinal value of artocarpus |
| 872 | 1 | 0.01 | quercus infectoria used in child care |
| 873 | 1 | 0.01 | pleiocarpine ?q=pleiocarpine |
| 874 | 1 | 0.01 | public perception on health lahore |
| 875 | 1 | 0.01 | pharmceutical research journals on micro... |
| 876 | 1 | 0.01 | permeability coefficient lipid diffusion... |
| 877 | 1 | 0.01 | secamone afzelii rhoem |
| 878 | 1 | 0.01 | c3 and c4 negative |
| 879 | 1 | 0.01 | analgesic and antipyretic, pdf |
| 880 | 1 | 0.01 | orally disintegraing tablets by ciproflo... |
| 881 | 1 | 0.01 | microbial test for blister pack |
| 882 | 1 | 0.01 | is til oil soluble in n butanol |
| 883 | 1 | 0.01 | drugs becoming a worldwide problem |
| 884 | 1 | 0.01 | acetaminophen acidic forced degradation |
| 885 | 1 | 0.01 | www.tjpr |
| 886 | 1 | 0.01 | curtent status of ethnoboyany |
| 887 | 1 | 0.01 | c3 sle |
| 888 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 889 | 1 | 0.01 | pharmaceutical research journal |
| 890 | 1 | 0.01 | pdf antimicrobial activities of medicina... |
| 891 | 1 | 0.01 | caraway in the african journal |
| 892 | 1 | 0.01 | drotaverine / mefenamic acid study |
| 893 | 1 | 0.01 | complement c4 serum high |
| 894 | 1 | 0.01 | desing,development and process validatio... |
| 895 | 1 | 0.01 | idowu et al. (1998) |
| 896 | 1 | 0.01 | anticancer pdf |
| 897 | 1 | 0.01 | tropical jkurnal of pharmaceutical resea... |
| 898 | 1 | 0.01 | c3 in sle pdf |
| 899 | 1 | 0.01 | arformoterol to salmeterol |
| 900 | 1 | 0.01 | history of nano drug delivery systems pa... |
| 901 | 1 | 0.01 | gastroretentive system |
| 902 | 1 | 0.01 | a grade pharmacist registration exam pap... |
| 903 | 1 | 0.01 | drug release for animal and nanotechnolo... |
| 904 | 1 | 0.01 | how to minimise pharmacy waiting time |
| 905 | 1 | 0.01 | quality of life index 2014 - nigeria |
| 906 | 1 | 0.01 | tablets with low disintegration properti... |
| 907 | 1 | 0.01 | nanotechnology definition pdf |
| 908 | 1 | 0.01 | multiparticulate drug delivery systems |
| 909 | 1 | 0.01 | how is pharmaceutical care a benefit for... |
| 910 | 1 | 0.01 | echium russeliana |
| 911 | 1 | 0.01 | mechanism of action of langli glory lily... |
| 912 | 1 | 0.01 | penetration inhancer |
| 913 | 1 | 0.01 | standard dispensing practices |
| 914 | 1 | 0.01 | c3&c4 in sle |
| 915 | 1 | 0.01 | cox inflamation cell |
| 916 | 1 | 0.01 | sepsis, lps in vitro |
| 917 | 1 | 0.01 | piper crocatum journal pdf |
| 918 | 1 | 0.01 | plasma degradation |
| 919 | 1 | 0.01 | orally disintegrating tablets |
| 920 | 1 | 0.01 | pharmaceutical validation steps |
| 921 | 1 | 0.01 | what does c3 and c4 measure |
| 922 | 1 | 0.01 | study of effects of cervical ulcer pdf |
| 923 | 1 | 0.01 | synthesis β-carboline alkaloids |
| 924 | 1 | 0.01 | impurities in extended release tablets |
| 925 | 1 | 0.01 | journal on microspheres of metformin hyd... |
| 926 | 1 | 0.01 | examples of formulations of drugs that i... |
| 927 | 1 | 0.01 | control release drug delivery system in ... |
| 928 | 1 | 0.01 | heavy metals in food articles |
| 929 | 1 | 0.01 | experiment on spectrophotometric analysi... |
| 930 | 1 | 0.01 | reccurance of brucellosis in human |
| 931 | 1 | 0.01 | oxygen transfer modeling of eye cells |
| 932 | 1 | 0.01 | mouth dissolving tablet a review article... |
| 933 | 1 | 0.01 | patent medicine vendors in rural areas o... |
| 934 | 1 | 0.01 | solubility and bioavailability enhanceme... |
| 935 | 1 | 0.01 | role of ethanol in microsphere preparati... |
| 936 | 1 | 0.01 | sublimation borneol |
| 937 | 1 | 0.01 | antimicrobial formulation use of limoni... |
| 938 | 1 | 0.01 | particulate drug delivery system |
| 939 | 1 | 0.01 | formoterol in human plasma by lcms cmax |
| 940 | 1 | 0.01 | cost of oral strips vs tablets |
| 941 | 1 | 0.01 | challenges facing vaccine devt against p... |
| 942 | 1 | 0.01 | detail about drug delivery application |
| 943 | 1 | 0.01 | skin permeability enhancers |
| 944 | 1 | 0.01 | pharmacophore |
| 945 | 1 | 0.01 | process invloved in drug production in a... |
| 946 | 1 | 0.01 | solid dispersion onfurosemide |
| 947 | 1 | 0.01 | uses of artocarpus chama |
| 948 | 1 | 0.01 | single unit dosage forms |
| 949 | 1 | 0.01 | spectrophotometric analysis of chloroqui... |
| 950 | 1 | 0.01 | permeation enhancement by using penetrat... |
| 951 | 1 | 0.01 | salvia pdf |
| 952 | 1 | 0.01 | alu for pregnant mother |
| 953 | 1 | 0.01 | validations steps of pharmaceuticals |
| 954 | 1 | 0.01 | antibiotics administration error in ward... |
| 955 | 1 | 0.01 | high total complement but normal c3 and ... |
| 956 | 1 | 0.01 | give reason for process validation pdf |
| 957 | 1 | 0.01 | diabetes mellitus insulin hepatitis c f... |
| 958 | 1 | 0.01 | construction of molecular motors as dru... |
| 959 | 1 | 0.01 | drug delivery nanotechnology pdf |
| 960 | 1 | 0.01 | what about tafawa balewa university facu... |
| 961 | 1 | 0.01 | theophylin sulphate uses |
| 962 | 1 | 0.01 | validation pharmaeuticals company |
| 963 | 1 | 0.01 | anti ulcer activity of leaves healing an... |
| 964 | 1 | 0.01 | ana dsdna c3 c4 |
| 965 | 1 | 0.01 | aurones pdf |
| 966 | 1 | 0.01 | level of ejournal manager |
| 967 | 1 | 0.01 | journal on the effect of productquality ... |
| 968 | 1 | 0.01 | film strip disadvantages in otc disadvan... |
| 969 | 1 | 0.01 | lupus nephritis and complement levels |
| 970 | 1 | 0.01 | mefenamic acid uv spectrum |
| 971 | 1 | 0.01 | the production processes of a pharmacy |
| 972 | 1 | 0.01 | pharmacy university or college in usa fo... |
| 973 | 1 | 0.01 | penetration enhancer . |
| 974 | 1 | 0.01 | pharmaceutical review of limonia acidiss... |
| 975 | 1 | 0.01 | filetype:pdf jurnal piper crocatum |
| 976 | 1 | 0.01 | low c4 normal c3 lupus |
| 977 | 1 | 0.01 | what is serology used for |
| 978 | 1 | 0.01 | theophylline drug content estimation |
| 979 | 1 | 0.01 | validation in the pharmaceutical industr... |
| 980 | 1 | 0.01 | salimi anayatollah |
| 981 | 1 | 0.01 | rapid tablet formula |
| 982 | 1 | 0.01 | downlode l pdf of anticholine sterases d... |
| 983 | 1 | 0.01 | c4 level in lupus |
| 984 | 1 | 0.01 | concentration of chloroquine standard so... |
| 985 | 1 | 0.01 | tetracycline in saureus |
| 986 | 1 | 0.01 | pharmacy practuce in nigeria |
| 987 | 1 | 0.01 | sop process validation of manufacturing ... |
| 988 | 1 | 0.01 | level of partial pressure of oxygen whe... |
| 989 | 1 | 0.01 | different formulation of senna |
| 990 | 1 | 0.01 | ftropical journal of pharmaceutical rese... |
| 991 | 1 | 0.01 | monitoring of internal and external fact... |
| 992 | 1 | 0.01 | morinda morindoides |
| 993 | 1 | 0.01 | transdermal drug delivery system review |
| 994 | 1 | 0.01 | tahanie qhewii |
| 995 | 1 | 0.01 | targets forartesunate |
| 996 | 1 | 0.01 | soluble tablets fast dissolving |
| 997 | 1 | 0.01 | positive c3 and c4 complement |
| 998 | 1 | 0.01 | study on medicinal herbal toothpaste for... |
| 999 | 1 | 0.01 | antimicrobial and stevia |
| 1000 | 1 | 0.01 | antipyretic pdf |
| 1001 | 1 | 0.01 | c3 c4 ranges |
| 1002 | 1 | 0.01 | determine quality of milk sample by meth... |
| 1003 | 1 | 0.01 | optimized formulation of |
| 1004 | 1 | 0.01 | lupus and low complement levels |
| 1005 | 1 | 0.01 | mechanisms of adverse drug reactions |
| 1006 | 1 | 0.01 | effect of m.wt. of polymer on the releas... |
| 1007 | 1 | 0.01 | low c 3 and normal c 4 |
| 1008 | 1 | 0.01 | assay of chloroquine phosphate using non... |
| 1009 | 1 | 0.01 | what is diagnosis of low c3 and c4 level... |
| 1010 | 1 | 0.01 | review on evaluation of buccal tablet p... |
| 1011 | 1 | 0.01 | chloroform and chloroquine phosphate |
| 1012 | 1 | 0.01 | carissa carandas plant activity |
| 1013 | 1 | 0.01 | validation in pharmaceutical industry |
| 1014 | 1 | 0.01 | research article of buccal patches |
| 1015 | 1 | 0.01 | tfr binding peptide screened by phage di... |
| 1016 | 1 | 0.01 | preparation methods of multiparticulate ... |
| 1017 | 1 | 0.01 | pronase inhibitor copper sulfate |
| 1018 | 1 | 0.01 | curcumin kidney histopathelogy |
| 1019 | 1 | 0.01 | calibration plot method of assay of chlo... |
| 1020 | 1 | 0.01 | dissolution tester |
| 1021 | 1 | 0.01 | duodenum contraction recording setup |
| 1022 | 1 | 0.01 | stevia rebaudiana ash |
| 1023 | 1 | 0.01 | pharmacology for download in labtop |
| 1024 | 1 | 0.01 | permeation enhancement by using penetrat... |
| 1025 | 1 | 0.01 | oral dosage form disintegration test |
| 1026 | 1 | 0.01 | pharmaceutical validation protocols |
| 1027 | 1 | 0.01 | department of chemistry usmanu danfodiyo... |
| 1028 | 1 | 0.01 | mefenamic acid and fluorecence spectral |
| 1029 | 1 | 0.01 | how can we conclude hplc method is stabi... |
| 1030 | 1 | 0.01 | oct-4 expression tumor cells |
| 1031 | 1 | 0.01 | moneghini m, voinovich d, perissutti b, ... |
| 1032 | 1 | 0.01 | metronidazole blood parameters pdf |
| 1033 | 1 | 0.01 | adebiyi o olowu email |
| 1034 | 1 | 0.01 | tjpr?q=tjpr |
| 1035 | 1 | 0.01 | abere, a.t & n.o. doris. 2012. pharmacog... |
| 1036 | 1 | 0.01 | clinical pharmacy pilot regions hospital |
| 1037 | 1 | 0.01 | atherosclerotic rat |
| 1038 | 1 | 0.01 | tropical journal of pharmacutical resea... |
| 1039 | 1 | 0.01 | tropical journal of pharmaceiutical rese... |
| 1040 | 1 | 0.01 | serum c3 and c4 |
| 1041 | 1 | 0.01 | prevalence of uti among gender |
| 1042 | 1 | 0.01 | novel drug dilivery for multiple scleros... |
| 1043 | 1 | 0.01 | orodispersible ibuprofen |
| 1044 | 1 | 0.01 | phytochemical screening of dried galls o... |
| 1045 | 1 | 0.01 | emuslification/solvent diffusion |
| 1046 | 1 | 0.01 | carissa carandas reseaches |
| 1047 | 1 | 0.01 | dsc of cefuroxime axetil |
| 1048 | 1 | 0.01 | c3 low c4 normal blood |
| 1049 | 1 | 0.01 | assay of chloroquine phosphate tablets b... |
| 1050 | 1 | 0.01 | c4 complement 11 |
| 1051 | 1 | 0.01 | fast dissolving oral film consist of in... |
| 1052 | 1 | 0.01 | estevia+article+ |
| 1053 | 1 | 0.01 | ethnobotany pdf |
| 1054 | 1 | 0.01 | invitro test for surtaind relase tablate |
| 1055 | 1 | 0.01 | isaac karimi |
| 1056 | 1 | 0.01 | tropical journal of phar |
| 1057 | 1 | 0.01 | reducing bacteria in mouth |
| 1058 | 1 | 0.01 | userlist.asp? |
| 1059 | 1 | 0.01 | what is the disadvaantages of nano medi... |
| 1060 | 1 | 0.01 | penetration enhancers for drugs |
| 1061 | 1 | 0.01 | colorimetric methods developed on palipe... |
| 1062 | 1 | 0.01 | prevalence of e.coli in uti |
| 1063 | 1 | 0.01 | countries or hospitals where pharmaceuti... |
| 1064 | 1 | 0.01 | e.coli in uti pdf |
| 1065 | 1 | 0.01 | +high-fat diet +cholesterol |
| 1066 | 1 | 0.01 | suppositories |
| 1067 | 1 | 0.01 | antidiabetic agents malaysia |
| 1068 | 1 | 0.01 | jade used in nano tech |
| 1069 | 1 | 0.01 | evaluation of sustained release tablets ... |
| 1070 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 1071 | 1 | 0.01 | research about assessment knowledge and ... |
| 1072 | 1 | 0.01 | microsphere preparation |
| 1073 | 1 | 0.01 | safely issue related to nano drug delive... |
| 1074 | 1 | 0.01 | formulation and evaluation of mouth diss... |
| 1075 | 1 | 0.01 | effect of water fluoridation on oral bac... |
| 1076 | 1 | 0.01 | extraction of silybin |
| 1077 | 1 | 0.01 | antibacterial activity of limonia acidis... |
| 1078 | 1 | 0.01 | complete component c3c |
| 1079 | 1 | 0.01 | artemisinin suggested use |
| 1080 | 1 | 0.01 | differential low c4 |
| 1081 | 1 | 0.01 | microbiological evaluation of different ... |
| 1082 | 1 | 0.01 | low c4 normal c3 |
| 1083 | 1 | 0.01 | medication knowledge is highly correlate... |
| 1084 | 1 | 0.01 | is theophylline soluble in acetone? |
| 1085 | 1 | 0.01 | in process control pharmaceutical |
| 1086 | 1 | 0.01 | low c3 level |
| 1087 | 1 | 0.01 | okpalugo et al 2008 |
| 1088 | 1 | 0.01 | microsphere emulsion.pdf |
| 1089 | 1 | 0.01 | niosomal drug delivery with dicetyl pho... |
| 1090 | 1 | 0.01 | permeation enhancers, |
| 1091 | 1 | 0.01 | pharmacological actions of cidrus deoder... |
| 1092 | 1 | 0.01 | trop j. pharma res. |
| 1093 | 1 | 0.01 | trop j pharm |
| 1094 | 1 | 0.01 | stevia and anti cancer article download |
| 1095 | 1 | 0.01 | process control articles pdf |
| 1096 | 1 | 0.01 | low c3 normal c4 differential |
| 1097 | 1 | 0.01 | knowlege of mother/care givers on cause ... |
| 1098 | 1 | 0.01 | low c3 differential diagnosis normal c4 |
| 1099 | 1 | 0.01 | ppt on sln application for gene delivery |
| 1100 | 1 | 0.01 | effect jasmonat on plant+review2014 |
| 1101 | 1 | 0.01 | compression coated tablet using eudragit... |
| 1102 | 1 | 0.01 | dsc scan of pure theophylline |
| 1103 | 1 | 0.01 | 4-fdc analysis hplc |
| 1104 | 1 | 0.01 | change control of pharmaceutical validat... |
| 1105 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
| 1106 | 1 | 0.01 | http://tjpr.org/jmanager/manuscript/logi... |
| 1107 | 1 | 0.01 | http://www.tjpr.org/vol8_no6/2009_8_6_6_... |
| 1108 | 1 | 0.01 | http://www.tjpr.org/vol8_no3/2009_8_3_7_... |
| 1109 | 1 | 0.01 | journal of antipyretic filetype:pdf |
| 1110 | 1 | 0.01 | effect of zeta potential on the properti... |
| 1111 | 1 | 0.01 | isolation & identification of causative ... |
| 1112 | 1 | 0.01 | diabetes and chemical enhancers in scien... |
| 1113 | 1 | 0.01 | cache:http://www.tjpr.org/vol7_no1/714it... |
| 1114 | 1 | 0.01 | amar@ajums.ac.ir loc:us |
| 1115 | 1 | 0.01 | antibiotic resistivity pattern of spoila... |
| 1116 | 1 | 0.01 | complement deficiency low c3 |
| 1117 | 1 | 0.01 | process control systems in the manufactu... |
| 1118 | 1 | 0.01 | method developmnt by using uv articles |
| 1119 | 1 | 0.01 | low c3 and c4 level |
| 1120 | 1 | 0.01 | tablet film coating pdf |
| 1121 | 1 | 0.01 | spectrophotometric methods for angiotens... |
| 1122 | 1 | 0.01 | stevia anticancer properties+pdf |
| 1123 | 1 | 0.01 | which complement deficiency highest risk... |
| 1124 | 1 | 0.01 | c4 concentration measure |
| 1125 | 1 | 0.01 | albezia gum |
| 1126 | 1 | 0.01 | alstonia boonei journal works pdf |
| 1127 | 1 | 0.01 | prostate cancer |
| 1128 | 1 | 0.01 | what is a multiparticulate system |
| 1129 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1130 | 1 | 0.01 | what is pharmaceutical methods -books |
| 1131 | 1 | 0.01 | improvement carbamazepine bioavailabilit... |
| 1132 | 1 | 0.01 | if i have a c4 low level is that lupus |
| 1133 | 1 | 0.01 | antibacterial effect of methanol fruit e... |
| 1134 | 1 | 0.01 | "detection in various'' |
| 1135 | 1 | 0.01 | doaj pharmacology journals both print an... |
| 1136 | 1 | 0.01 | mathematical model of drug distribution ... |
| 1137 | 1 | 0.01 | knowledge on malaria prevention among mo... |
| 1138 | 1 | 0.01 | nano drug delivery pdf |
| 1139 | 1 | 0.01 | naproxen carragenan induced paw inflamma... |
| 1140 | 1 | 0.01 | can a low c4 and normal c3 indicate lupu... |
| 1141 | 1 | 0.01 | c3 and c4 serum complement |
| 1142 | 1 | 0.01 | validation in drug development |
| 1143 | 1 | 0.01 | tropical j of pharmaceutical research |
| 1144 | 1 | 0.01 | validation of pharmaceutical process |
| 1145 | 1 | 0.01 | commonly used pharmacological categories... |
| 1146 | 1 | 0.01 | carbomer encapsulation |
| 1147 | 1 | 0.01 | pdf of natural mucoadhessive polymer |
| 1148 | 1 | 0.01 | low c4 complement |
| 1149 | 1 | 0.01 | tramadol benin |
| 1150 | 1 | 0.01 | formulation & development as an antidiab... |
| 1151 | 1 | 0.01 | disintegration and dissolution test for ... |
| 1152 | 1 | 0.01 | decreased c3 |
| 1153 | 1 | 0.01 | essential bioinformatics pdf |
| 1154 | 1 | 0.01 | prof. patrick erah |
| 1155 | 1 | 0.01 | paper for bacterial contamination of ora... |
| 1156 | 1 | 0.01 | validation of absorbance ratio method |
| 1157 | 1 | 0.01 | niosomal antibiotic |
| 1158 | 1 | 0.01 | nanotechnology in drug delivery |
| 1159 | 1 | 0.01 | mould contamination tablets |
| 1160 | 1 | 0.01 | microspheres drug delivery evaluation |
| 1161 | 1 | 0.01 | mouth bacteria pdf |
| 1162 | 1 | 0.01 | efficiency of different toothpastes |
| 1163 | 1 | 0.01 | how to determine enzyme activity of l as... |
| 1164 | 1 | 0.01 | illegible handwritinf scale |
| 1165 | 1 | 0.01 | lupus c3 and c4 |
| 1166 | 1 | 0.01 | validation for pharmaceutical equipment |
| 1167 | 1 | 0.01 | silica plate for teeth reducing |
| 1168 | 1 | 0.01 | scheduled m content |
| 1169 | 1 | 0.01 | 2009_8_2_10_hirani.pdf |
| 1170 | 1 | 0.01 | curative propertis marigold plant |
| 1171 | 1 | 0.01 | drug delivery system using nanotechnolog... |
| 1172 | 1 | 0.01 | development of novel oral dosage forms f... |
| 1173 | 1 | 0.01 | brucellosis peritonitis |
| 1174 | 1 | 0.01 | betahistine hplc method |
| 1175 | 1 | 0.01 | c4 level 45 |
| 1176 | 1 | 0.01 | what is potential antioxidant meaning in... |
| 1177 | 1 | 0.01 | tropical journal of pharmaceut |
| 1178 | 1 | 0.01 | "jiangnan university" author:ruijin auth... |
| 1179 | 1 | 0.01 | what type of antibiotic can be used to c... |
| 1180 | 1 | 0.01 | bac for driving in nigeria |
| 1181 | 1 | 0.01 | high c4 complement levels amyloidosis |
| 1182 | 1 | 0.01 | how to develop analytical method on uv |
| 1183 | 1 | 0.01 | herbal medicines pdf |
| 1184 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/7310_sreeni... |
| 1185 | 1 | 0.01 | nano drug delivery review |
| 1186 | 1 | 0.01 | pdf on neutrceutical |
| 1187 | 1 | 0.01 | preparation of eudragit microspheres |
| 1188 | 1 | 0.01 | levels of pharmaceutical care |
| 1189 | 1 | 0.01 | is africa ready to treat hypertension |
| 1190 | 1 | 0.01 | evaluation of ginsenoside rg1 as a poten... |
| 1191 | 1 | 0.01 | dissolution test procedure for mefenamic... |
| 1192 | 1 | 0.01 | advantages of biphasic property of prolo... |
| 1193 | 1 | 0.01 | anticancer plants pdf |
| 1194 | 1 | 0.01 | amoxicillin and caffeine interaction |
| 1195 | 1 | 0.01 | dimethyl sulphoxide drug increase the pe... |
| 1196 | 1 | 0.01 | pharmaceutical research |
| 1197 | 1 | 0.01 | penicillin and caffeine |
| 1198 | 1 | 0.01 | permeation enhancement by penetration en... |
| 1199 | 1 | 0.01 | orally disintegrating tablets review |
| 1200 | 1 | 0.01 | ondansetron transdermal patch |
| 1201 | 1 | 0.01 | role of complement in diagnosis |
| 1202 | 1 | 0.01 | projects done in pharmaceutical microbio... |
| 1203 | 1 | 0.01 | pyrazoline derivatives pdf |
| 1204 | 1 | 0.01 | uv hairless topical application |
| 1205 | 1 | 0.01 | type of validation in pharma |
| 1206 | 1 | 0.01 | solidification point+witepsol |
| 1207 | 1 | 0.01 | penetration enhancer pdf |
| 1208 | 1 | 0.01 | pdf form of using bioinformatics for dru... |
| 1209 | 1 | 0.01 | serum c3 |
| 1210 | 1 | 0.01 | niosomes-methods of drug entrapment |
| 1211 | 1 | 0.01 | nauclea latifolia ethnobotanic study in ... |
| 1212 | 1 | 0.01 | okemo |
| 1213 | 1 | 0.01 | normal ana with low c3c4 |
| 1214 | 1 | 0.01 | crushing strength - dry maize |
| 1215 | 1 | 0.01 | asparaginase screening and purification |
| 1216 | 1 | 0.01 | cemitidine pulsitile dds pdf |
| 1217 | 1 | 0.01 | amol a kulkarni christopher l. king, tif... |
| 1218 | 1 | 0.01 | "type 2 diabetes" |
| 1219 | 1 | 0.01 | antioxident screening test |
| 1220 | 1 | 0.01 | graph of dissolution study of controlled... |
| 1221 | 1 | 0.01 | karnataka gloriosa plant |
| 1222 | 1 | 0.01 | low c3, c4 |
| 1223 | 1 | 0.01 | purpose of re validation of cleaning |
| 1224 | 1 | 0.01 | pharmaceutical care plan for hypertensio... |
| 1225 | 1 | 0.01 | pharma compliance validated testing |
| 1226 | 1 | 0.01 | normal c3 c4 range |
| 1227 | 1 | 0.01 | pharma validation |
| 1228 | 1 | 0.01 | journal of pharmaceutical research |
| 1229 | 1 | 0.01 | formulation tablet with kaolin and neomi... |
| 1230 | 1 | 0.01 | glipizide |
| 1231 | 1 | 0.01 | low serum c3 and normal c4 |
| 1232 | 1 | 0.01 | multiparticulate floating drug delivery ... |
| 1233 | 1 | 0.01 | psidium guajava vs vernonia amygdalina |
| 1234 | 1 | 0.01 | tramadol hydrochloride matrix tablets j... |
| 1235 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
| 1236 | 1 | 0.01 | sitosterol b-glucoside nmr data in dmso ... |
| 1237 | 1 | 0.01 | the common complaints associated with ar... |
| 1238 | 1 | 0.01 | akbari et al., 2010 |
| 1239 | 1 | 0.01 | carvidilol phosphate factoral design |
| 1240 | 1 | 0.01 | anti-leukemic activity of wattakaka volu... |
| 1241 | 1 | 0.01 | solvent to penetrate body fat |
| 1242 | 1 | 0.01 | self administered pharmaceutical care qu... |
| 1243 | 1 | 0.01 | "hiv / aids" research treatment |
| 1244 | 1 | 0.01 | microbiology department in niprd |
| 1245 | 1 | 0.01 | penetration enhancer in pharma times |
| 1246 | 1 | 0.01 | idowu,et al.1998 |
| 1247 | 1 | 0.01 | do odt formulations undergo 1st pass met... |
| 1248 | 1 | 0.01 | how long tio cook a turkey weighing 1.44... |
| 1249 | 1 | 0.01 | ccare.inayat@rediffmail.com |
| 1250 | 1 | 0.01 | benefits of pharmaceutical care |
| 1251 | 1 | 0.01 | mobile phase for artemether and lumefant... |
| 1252 | 1 | 0.01 | serum compliment studies |
| 1253 | 1 | 0.01 | phytochemical constituent of secamone af... |
| 1254 | 1 | 0.01 | phenolphthalein capsules weight loss dos... |
| 1255 | 1 | 0.01 | permeation enhancement by using penetrat... |
| 1256 | 1 | 0.01 | pharmaceutical product development docum... |
| 1257 | 1 | 0.01 | formulation of metformin controllede rea... |
| 1258 | 1 | 0.01 | median lethal dose and shrimp rats |
| 1259 | 1 | 0.01 | http://www.tjpr.org/vol1%20no1/iwuagwu.p... |
| 1260 | 1 | 0.01 | multiparticulate drug delivery system pe... |
| 1261 | 1 | 0.01 | use of gloriosa superba on pdf |
| 1262 | 1 | 0.01 | validation meaning in pharma |
| 1263 | 1 | 0.01 | validation of batch of pharmaceutical dr... |
| 1264 | 1 | 0.01 | salbutamol sulphate odf papers |
| 1265 | 1 | 0.01 | typha domingensis flavonoids |
| 1266 | 1 | 0.01 | anti ulcer studies in mice |
| 1267 | 1 | 0.01 | a textbook of nanotechnology 36 mb |
| 1268 | 1 | 0.01 | an acid is an electron pair acceptor and... |
| 1269 | 1 | 0.01 | ciprofloxacin physicochemical properties... |
| 1270 | 1 | 0.01 | antioxidant value of marigold leaves,pdf |
| 1271 | 1 | 0.01 | complement levels in sle flare |
| 1272 | 1 | 0.01 | chloroquine assay caliberation curve |
| 1273 | 1 | 0.01 | appoptosis herbal extruct pdf |
| 1274 | 1 | 0.01 | antiinflammatory + sustained release for... |
| 1275 | 1 | 0.01 | review of articles: secondary metabolite... |
| 1276 | 1 | 0.01 | recent article on noni fruit |
| 1277 | 1 | 0.01 | research paper on in vitro release cellu... |
| 1278 | 1 | 0.01 | what are tumour markers for mesothelioma |
| 1279 | 1 | 0.01 | antiepileptic activity of medicinal plan... |
| 1280 | 1 | 0.01 | extraction of lepidium sativum |
| 1281 | 1 | 0.01 | effects of plant extract on alloxan indu... |
| 1282 | 1 | 0.01 | low c3 c4 |
| 1283 | 1 | 0.01 | in vitro interaction between caffeine |
| 1284 | 1 | 0.01 | literature review on nanotechnology |
| 1285 | 1 | 0.01 | low complement differential |
| 1286 | 1 | 0.01 | lps induced cox-2 activity in thp-1 cell... |
| 1287 | 1 | 0.01 | odt drugs advantages |
| 1288 | 1 | 0.01 | gastroretentive drug delivery system.pdf |
| 1289 | 1 | 0.01 | disintegration time of metronidazole |
| 1290 | 1 | 0.01 | eudragit |
| 1291 | 1 | 0.01 | ir spectrum of ciprofloxacin hydrochlori... |
| 1292 | 1 | 0.01 | hygrophila spinosa t. and benefit |
| 1293 | 1 | 0.01 | journal of tropical pharmaceutical scien... |
| 1294 | 1 | 0.01 | tetanus prophylaxis for snake bite |
| 1295 | 1 | 0.01 | physicochemical and powder properties of... |
| 1296 | 1 | 0.01 | piper crocatum author name |
| 1297 | 1 | 0.01 | bafor |
| 1298 | 1 | 0.01 | why is it useful to estimate the number ... |
| 1299 | 1 | 0.01 | tropical journal of pharmaceutical rese... |
| 1300 | 1 | 0.01 | compliment c3 and c4 normal but low |
| 1301 | 1 | 0.01 | best transdermal delivery chemicals |
| 1302 | 1 | 0.01 | cyp7a1 |
| 1303 | 1 | 0.01 | "su zi-ren" |
| 1304 | 1 | 0.01 | stability indicating method of sulfasala... |
| 1305 | 1 | 0.01 | research articles on breadfruit pdfs |
| 1306 | 1 | 0.01 | journal role of superoxide dismutase in ... |
| 1307 | 1 | 0.01 | pdf files on nephro-protective effect of... |
| 1308 | 1 | 0.01 | orodispersible tablets pdf |
| 1309 | 1 | 0.01 | pleurotus tuber regium |
| 1310 | 1 | 0.01 | limits for contaminant un tablets |
| 1311 | 1 | 0.01 | adv. drug del. rev. 56, 603-618 ac will... |
| 1312 | 1 | 0.01 | cross carmellose sodium peaks wave no ft... |
| 1313 | 1 | 0.01 | mannitol for orodispersible tablets |
| 1314 | 1 | 0.01 | low c3 and c4 |
| 1315 | 1 | 0.01 | mouthd dissolving tablets rational |
| 1316 | 1 | 0.01 | emil salim universiti kebangsaan malaysi... |
| 1317 | 1 | 0.01 | http://www.tjpr.org/vol7_no1/718madan.pd... |
| 1318 | 1 | 0.01 | side effect of different antimalarial dr... |
| 1319 | 1 | 0.01 | www.example of drug in ethiopia |
| 1320 | 1 | 0.01 | c3 and c4 |
| 1321 | 1 | 0.01 | actinomycetes enzyme |
| 1322 | 1 | 0.01 | igbeneghu tropical journal pharmaceutica... |
| 1323 | 1 | 0.01 | tjpr behnam hoseinzadeh |
| 1324 | 1 | 0.01 | side effects of acts |
| 1325 | 1 | 0.01 | patronage of patent medicine dealers |
| 1326 | 1 | 0.01 | low c3 normal c4 |
| 1327 | 1 | 0.01 | low c4 level in blood, positive ana, nor... |
| 1328 | 1 | 0.01 | price of cooling pad sensor in greenhous... |
| 1329 | 1 | 0.01 | reserch articles on topical emlusion |
| 1330 | 1 | 0.01 | traditional medicines pdf |
| 1331 | 1 | 0.01 | symtoms of lupus c3 and c4 and kidneys |
| 1332 | 1 | 0.01 | mtor chicken |
| 1333 | 1 | 0.01 | pediatric thin rapidly dissolving films ... |
| 1334 | 1 | 0.01 | studies on wound healing |
| 1335 | 1 | 0.01 | journal of antibiotics that is susceptib... |
| 1336 | 1 | 0.01 | formulation and evaluation of controlled... |
| 1337 | 1 | 0.01 | chemical equivalence pharmacy |
| 1338 | 1 | 0.01 | antipyretic thesis pdf |
| 1339 | 1 | 0.01 | chinese medicine |
| 1340 | 1 | 0.01 | paste toothpaste manufacturing formula ... |
| 1341 | 1 | 0.01 | manufacture of acetaminophen orally disi... |
| 1342 | 1 | 0.01 | martin's physical pharmacy and pharmaceu... |
| 1343 | 1 | 0.01 | patchouli alcohol nmr assignment |
| 1344 | 1 | 0.01 | recent penetration enhancer news in phar... |
| 1345 | 1 | 0.01 | 의약품 validation |
| 1346 | 1 | 0.01 | xiao yi china pharmaceutical university |
| 1347 | 1 | 0.01 | tropical journal and pharmaceutiacl rese... |
| 1348 | 1 | 0.01 | watching pattern of sales in pharmacy |
| 1349 | 1 | 0.01 | prevalence of hiv hbv hcv and syphilis a... |
| 1350 | 1 | 0.01 | relative use value in ethnomedicine stud... |
| 1351 | 1 | 0.01 | tjper |
| 1352 | 1 | 0.01 | review "drug delivery" research develo... |
| 1353 | 1 | 0.01 | emulsion method for microshere preparati... |
| 1354 | 1 | 0.01 | e.coli urine antibiotic resistance pdf |
| 1355 | 1 | 0.01 | zheng quan an |
| 1356 | 1 | 0.01 | tropical journal of pharmaceutical rese... |
| 1357 | 1 | 0.01 | magnolia effect of interleukin 6+pdf |
| 1358 | 1 | 0.01 | http://www.tjpr.org/vol10_no2/2011_10_2_... |
| 1359 | 1 | 0.01 | hydro alcoholic coating |
| 1360 | 1 | 0.01 | nutraceutical pathankot |
| 1361 | 1 | 0.01 | patern use of nsaids |
| 1362 | 1 | 0.01 | leuprolide acetate hplc 100 5 c18 |
| 1363 | 1 | 0.01 | lepidium sativum and diabetes pdf |
| 1364 | 1 | 0.01 | image of gentamicin induced nephrotoxici... |
| 1365 | 1 | 0.01 | compound ragacanth powder bp |
| 1366 | 1 | 0.01 | c4 lupus glomerulonephritis' |
| 1367 | 1 | 0.01 | guideline.dissolution testing.mefenamic ... |
| 1368 | 1 | 0.01 | drugs in relation introduction to nanote... |
| 1369 | 1 | 0.01 | pathar si,khankari r,siebert j. quik dis... |
| 1370 | 1 | 0.01 | methocel e 15 concentration for sustain ... |
| 1371 | 1 | 0.01 | mehrdad-ghasemi@minalon.com loc:us |
| 1372 | 1 | 0.01 | orally disintegrating tablets avoid firs... |
| 1373 | 1 | 0.01 | research work on newbouldia laevis in th... |
| 1374 | 1 | 0.01 | self medication among health care and no... |
| 1375 | 1 | 0.01 | simulated saliva composition indian phar... |
| 1376 | 1 | 0.01 | c3 c4 in lupus |
| 1377 | 1 | 0.01 | what are the causes of a decreased comp... |
| 1378 | 1 | 0.01 | pyrazoline derivatives |
| 1379 | 1 | 0.01 | process validation pdf |
| 1380 | 1 | 0.01 | quality control procedures for biopharma... |
| 1381 | 1 | 0.01 | research article on fast dissolving tabl... |
| 1382 | 1 | 0.01 | anticancer effect of extract |
| 1383 | 1 | 0.01 | bradford hill’s criteria individual ca... |
| 1384 | 1 | 0.01 | tropical jouranl of pharmacy |
| 1385 | 1 | 0.01 | stability of senna in a compound |
| 1386 | 1 | 0.01 | c3 and c4 levels in lupus |
| 1387 | 1 | 0.01 | metformin alginate bead sustaint release... |
| 1388 | 1 | 0.01 | melike üner |
| 1389 | 1 | 0.01 | microbiological quality of youghort |
| 1390 | 1 | 0.01 | interaction na-hyaluronat and urea in fo... |
| 1391 | 1 | 0.01 | meloxicam tablet formulation |
| 1392 | 1 | 0.01 | in process quality control chek peramete... |
| 1393 | 1 | 0.01 | hypertension management in nigeria |
| 1394 | 1 | 0.01 | dmso skin texture |
| 1395 | 1 | 0.01 | facilitating extended release medication... |
| 1396 | 1 | 0.01 | http://www.tjpr.org/vol10_no2/2011_10_2_... |
| 1397 | 1 | 0.01 | standard dose of acid phos for albino ra... |
| 1398 | 1 | 0.01 | owolabi et.al medicinal plants |
| 1399 | 1 | 0.01 | optimization and formulation of orodispe... |
| 1400 | 1 | 0.01 | normal c3 low c4 |
| 1401 | 1 | 0.01 | orally disintegrating tablets: a review |
| 1402 | 1 | 0.01 | metformin hcl alginate bead perparatio... |
| 1403 | 1 | 0.01 | tramadol lotion |
| 1404 | 1 | 0.01 | analysis of phenolphtalein by hplc |
| 1405 | 1 | 0.01 | mouth dissolving tablet formulation pdf |
| 1406 | 1 | 0.01 | formulation and evaluation of transderma... |
| 1407 | 1 | 0.01 | formulation and evaluation of controlled... |
| 1408 | 1 | 0.01 | isolation of urinary tract pathogens |
| 1409 | 1 | 0.01 | computer assisted pharmaceutical servic... |
| 1410 | 1 | 0.01 | complement c3 values in lupus patients |
| 1411 | 1 | 0.01 | effect of herbal plants on extended spec... |
| 1412 | 1 | 0.01 | nigerian journal of pharmaceutical scien... |
| 1413 | 1 | 0.01 | journal growth regulators auxin of rauvo... |
| 1414 | 1 | 0.01 | fractional crystallization of volatile o... |
| 1415 | 1 | 0.01 | how to carry out the test mircobial qual... |
| 1416 | 1 | 0.01 | stévia |
| 1417 | 1 | 0.01 | salib jy, michael hn, el-nogoumy si. new... |
| 1418 | 1 | 0.01 | what enhances drug penetration through s... |
| 1419 | 1 | 0.01 | tropical journal of pharmaceutical res |
| 1420 | 1 | 0.01 | www.tropical journal of pharmaciutical |
| 1421 | 1 | 0.01 | mohd.javed qureshi |
| 1422 | 1 | 0.01 | inflammation drug sales |
| 1423 | 1 | 0.01 | genotoxicity full text |
| 1424 | 1 | 0.01 | m.uzair@ephlux.com loc:us |
| 1425 | 1 | 0.01 | &ptb=3e0a572b-aa67-4b65-a769-6599e2c1ef6... |
| 1426 | 1 | 0.01 | (preference in oral) & iv vs tablet vs c... |
| 1427 | 1 | 0.01 | dermal drug delivery*pdf |
| 1428 | 1 | 0.01 | controlled drug delivery depend on |
| 1429 | 1 | 0.01 | formulaton and evaluation of sustained r... |
| 1430 | 1 | 0.01 | review article on complementary dna (cdn... |
| 1431 | 1 | 0.01 | pulsatile drug delivery |
| 1432 | 1 | 0.01 | nephrotoxicity cast rats pdf |
| 1433 | 1 | 0.01 | research on stevia |
| 1434 | 1 | 0.01 | "the mathematical analysis for distribut... |
| 1435 | 1 | 0.01 | types of process validation pdf |
| 1436 | 1 | 0.01 | why use aceclofenac sustained releasr t |
| 1437 | 1 | 0.01 | biotech@rajathi.com?q=biotech@rajathi.co... |
| 1438 | 1 | 0.01 | types of validation in pharmaceutical in... |
| 1439 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1440 | 1 | 0.01 | polymer used swelling gastroretentive d... |
| 1441 | 1 | 0.01 | tunel assay cancer cells |
| 1442 | 1 | 0.01 | normal c3 low c4 complement |
| 1443 | 1 | 0.01 | low c3 |
| 1444 | 1 | 0.01 | mouth dissolving tablet of famotidine re... |
| 1445 | 1 | 0.01 | pharmaceutical care service |
| 1446 | 1 | 0.01 | pharmacological activities of gloriosa s... |
| 1447 | 1 | 0.01 | vaibhav iftm |
| 1448 | 1 | 0.01 | what is meant by validation related to p... |
| 1449 | 1 | 0.01 | transdermal drug delivery system review ... |
| 1450 | 1 | 0.01 | ethylcellulose and chitosan microspheres... |
| 1451 | 1 | 0.01 | chemical research in chinese university |
| 1452 | 1 | 0.01 | defination of validation in pharma |
| 1453 | 1 | 0.01 | in vitro release pdf |
| 1454 | 1 | 0.01 | idowu et al 1998 |
| 1455 | 1 | 0.01 | low complement component c3c |
| 1456 | 1 | 0.01 | evren algÄn yapar |
| 1457 | 1 | 0.01 | antimicrobial activity of tamarindus ind... |
| 1458 | 1 | 0.01 | validation in pharmaceutical industry pd... |
| 1459 | 1 | 0.01 | analysis of toothpaste.pdf |
| 1460 | 1 | 0.01 | brucella titre |
| 1461 | 1 | 0.01 | osmotic tablet formulation |
| 1462 | 1 | 0.01 | nano drug essay with abstract |
| 1463 | 1 | 0.01 | mohammed abdalbasit a gasmalla |
| 1464 | 1 | 0.01 | microbiological validation of dm plants |
| 1465 | 1 | 0.01 | mohammed abdalbasit gasmalla |
| 1466 | 1 | 0.01 | phytosterol 2013 |
| 1467 | 1 | 0.01 | stevia rebaudiana cytotoxicity |
| 1468 | 1 | 0.01 | triloba fern |
